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ABSTRACT 
 
Pigment dispersion syndrome (PDS) is an ocular condition predisposing to 
glaucomatous optic neuropathy in patients at a relatively young age. Concavity of the 
iris is considered to be important in the pathogenesis of PDS, however, it is also 
appears to be a feature of non-PDS eyes, particularly in young myopes. Much of the 
current understanding of anterior segment anatomy is derived from studies using 
ultrasound biomicroscopy, a relatively invasive imaging modality that involves direct 
ocular contact. Anterior-segment optical coherence tomography (AS-OCT) allows 
imaging of the anterior segment with the patient in the upright position without the 
need for contact with the ocular surface. AS-OCT may allow a more physiological 
assessment of anterior segment anatomy as well as being better suited to paediatric 
subjects. AS-OCT was used to conduct a case-control study of anterior segment 
anatomy in PDS subjects and age-, sex- and refraction- matched controls to determine 
which features of anterior segment anatomy best discriminated between the 2 groups. 
In addition AS-OCT was used to assess anterior segment anatomy, with particular 
emphasis on iris curvature, in a cohort of 10-12 year old school children and explore 
correlations with ocular biometry and parameters reflecting corneal biomechanical 
properties. Longitudinal data was collected through re-visiting the cohort 2 years later.  
 
Chromosomal susceptibility loci for PDS have been described, although no causative 
gene has been identified. Two approaches were used to identify novel disease 
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susceptibility loci: 1) linkage analysis was used in a 3-generation family segregating for 
PDS/pigmentary glaucoma, and, 2) DNA from a large cohort of unrelated PDS probands 
was collected and sent for genotyping with a view to conducting a pilot genome-wide 
association study. Finally a candidate gene, GPNMB, the human homologue of a 
causative gene in a mouse model of pigmentary glaucoma was sequenced in a panel of 
96 unrelated PDS/pigmentary glaucoma subjects. 
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1.1 Glaucoma  
 
1.1.1  Definition 
 
The term ‘glaucoma’ encompasses a heterogeneous number of conditions which have 
in common an optic neuropathy characterized by specific structural findings in the 
optic disc and specific functional deficits detected by automated visual field testing (1).  
Raised intraocular pressure (IOP) is an important risk factor but not a defining feature 
of the disease.  
 
1.1.2  Classification  
 
Glaucoma may be broadly classified as either open-angle, where the irido-corneal 
angle appears clinically normal, or closed-angle, where tissue (commonly peripheral 
iris) physically obstructs the drainage of aqueous humour into the trabecular 
meshwork (TM).  Differentiation between the 2 forms is significant with regard to 
management. Both open-angle and closed-angle glaucoma may be further divided into 
primary (no identifiable ocular comorbidity) and secondary causes. Secondary causes 
of open angle glaucoma (OAG) include pigment dispersion and pseudoexfoliation 
whilst secondary causes of closed angle glaucoma include rubeosis, plateau iris 
syndrome and uveitis (in the context of causing extensive adhesions between the 
peripheral iris and drainage angle (peripheral anterior synechiae). A proportion of 
 20 
patients with open angles will have glaucomatous optic neuropathy (GON) with IOP 
consistently less than the upper limit of the normal range (considered to be 21mmHg) 
and these patients are classified as having low- or normal-tension glaucoma. 
 
1.1.3  Epidemiology 
 
Glaucoma is the 2nd leading cause of blindness (defined as visual acuity of less than 
3/60, or a corresponding visual field loss to less than 10 degrees in the better eye with 
best possible correction) worldwide after cataracts (2). Quiqley et al. (3) estimated the 
combined prevalence of open and closed angle glaucoma to be 60 million with 8.4 
million bilaterally blind in 2010. Women were estimated to comprise 55% of OAG and 
70% of angle closure glaucoma (3). OAG is most prevalent in people of African descent 
whilst angle closure glaucoma is most prevalent in Chinese people (3). The projected 
numbers for 2020 are a combined prevalence of 79.6 million and 11.2 million 
bilaterally blind (3).  
 
1.1.4  Pathophysiology 
 
Raised IOP is the major risk factor for GON as evidenced by unilateral secondary 
glaucoma, experimentally induced glaucoma and observation of the effects of IOP 
lowering in glaucoma patients (4) whilst the Collaborative Normal Tension Study was 
the  first clinical trial to demonstrate that IOP lowering reduced the rate of glaucoma 
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progression (5). Raised IOP may cause compression of retinal nerve fibres against 
lamina cribrosa with interruption of axoplasmic flow (mechanical theory). An 
alternative theory is that raised IOP compromises blood supply to the optic nerve head 
(ischaemic theory). Disturbance in autoregulation of the blood supply to the optic 
nerve may also contribute with raised IOP leading to reduced perfusion or the 
occurrence of vasospasm even at normal levels of IOP (4). 
 
1.1.5  Clinical evaluation 
 
The National Institute for Health and Clinical Excellence (NICE) have issued guidance on 
diagnosis, monitoring and treatment of chronic open angle glaucoma and OHT (6). 
Initial evaluation should include IOP measurement using Goldmann applanation 
tonometry, central corneal thickness (CCT) measurement, peripheral anterior chamber 
configuration and depth assessments using gonioscopy, visual field measurement using 
standard automated perimetry, optic nerve assessment after pupil dilatation, using 
stereoscopic slit lamp biomicroscopy with fundus examination. Automated imaging 
technologies have been developed which allow assessment of the optic disc and nerve 
fibre layer. Scanning laser ophthalmoscopy and optical coherence tomography (OCT) 
have a role in baseline assessment and monitoring for progression of GON. 
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1.1.6  Management 
 
IOP is the major modifiable risk factor for development of GON and current treatment 
options aim to lower IOP to a ‘target pressure’, which a clinician determines would 
prevent the development of visual disability (or prevent its worsening) within the 
patient’s lifetime. Typically the target pressure is set lower if there is greater initial 
damage or multiple risk factors for progression. Treatment options include IOP 
lowering drops, laser treatment or surgery. Ocular perfusion pressure may also play a 
role in glaucoma pathogenesis (7) and clinicians may choose to modifying blood 
pressure in order to achieve a more favourable perfusion pressure. Finally, there has 
been considerable interest in the role of neuroprotective agents in protecting against 
optic nerve head damage although robust evidence supporting the use of such agents 
is presently  lacking; RCTs designed to measure the efficacy of neuroprotective agents 
would require long-term follow up in order to draw clinically meaningful conclusions 
(8) 
 
1.1.6.1  Topical therapy 
  
A typical first line treatment would be topical monotherapy with a prostaglandin 
analogue such as latanoprost, travoprost or bimatoprost which works by increasing 
uveo-scleral outflow. These drops may need to be switched to, or supplemented by, 
other classes of IOP lowering drops such as beta-blockers, carbonic anhydrase 
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inhibitors or alpha-2 adrenergic agonists. The predominant mechanism of action of 
these other agents is reduction of aqueous production. 
 
1.1.6.2  Laser trabeculoplasty 
 
If sufficient IOP lowering cannot be achieved with drops, then laser treatment may be 
offered.  
 
1.1.6.2.1 Argon laser trabeculoplasty 
 
Argon laser trabeculoplasty causes a thermal burn to the tissue causing tissue 
contraction and scar formation and this is thought to result in a mechanical stretching 
of the surrounding uveoscleral TM (9). A Cochrane review (10) of laser trabeculoplasty 
for OAG concluded that in newly diagnosed OAG participants, the risk of uncontrolled 
IOP at six months and two years of follow up is lower in patients treated with laser 
trabeculoplasty compared to those on medical treatment. The trials reviewed did not 
include newer classes of drops i.e. prostaglandin analogues, carbonic anhydrase 
inhibitors or alpha-2 agonists. For participants already on maximum medical therapy, 
the risk of uncontrolled IOP at six months was higher in patients treated by laser 
trabeculoplasty compared to surgery (trabeculectomy), however, the trials did not 
include trabeculectomy augmented by anti-metabolites and had these been included it 
is likely the difference between the modalities would have been even greater. The 
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American Academy of Ophthalmology published a review on laser trabeculoplasty (11) 
confirming the technique was effective at lowering IOP in patients with OAG.  
 
1.1.6.2.2 Selective laser trabeculoplasty 
 
There is considerable interest in selective laser trabeculoplasty (SLT), an alternative to 
argon, which uses a frequency-doubled short-pulsed (Q-switched) 
neodymium:yttrium–aluminium– garnet (YAG) laser.  It has been suggested that SLT 
works by stimulating macrophage recruitment and inducing changes in cytokines which 
stimulate extracellular matrix remodeling leasing to increased aqueous outflow (9). The 
laser in SLT is thought to be selectively taken up by the pigmented trabecular 
meshwork cells. The theoretical advantage of SLT over ALT is that there appears to be 
less coagulative and structural damage to the TM (12) and it may therefore be more 
suitable for repeat treatments. 
 
1.1.6.3  Surgery 
 
Surgery may be considered in patients at risk of sight loss despite treatment (6). 
Trabeculectomy lowers IOP by re-directing aqueous humour into the sub-conjunctival 
space, forming a bleb under the upper eyelid and creating an alternative pathway for 
aqueous humour outflow. Modern surgical techniques employ wound modulation with 
anti-metabolites (mitomycin C (MMC) or 5-fluorouracil (5-FU)) and placement of 
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releasable sutures which provide the option of increasing flow through the 
trabeculectomy in the post-operative period and reducing the risk of hypotony. Despite 
advances in surgical technique, excessive drainage can lead to hypotony, which may be 
associated with choroidal detachments and/or maculopathy, whilst excessive fibrosis 
can lead to bleb failure. There is a trend in some centres towards non-penetrating 
glaucoma surgery or procedures that enhance Schlemm’s canal. Whilst non-
penetrating techniques are accepted to have a better safety profile than 
trabeculectomy, post-operative IOP is not as low as that achieved by trabeculectomy 
(13-15) and the procedures have a longer learning curve (16). 
 
In cases where trabeculectomy has failed or in certain glaucoma subtypes there may be 
a preference instead to insert a glaucoma drainage device or ‘tube’ which serves to 
lower IOP by draining aqueous from the anterior chamber to the sub-conjunctival 
space. Data from a 5-year multi-centre randomised clinical trial (17), reported that 
trabeculectomy with MMC had a greater surgical failure rate than tube surgery 
although both procedures had similar rates of vision loss and late post-operative and 
serious complications. 
 
1.1.6.4  Management of angle closure 
 
The initial management of angle closure glaucoma involves making a hole in the 
peripheral iris, commonly with a YAG laser, in order to bypass ‘pupil block’, the 
anatomical configuration which causes the peripheral iris to bow forwards and close 
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the angle between the cornea and the iris. When iridotomy fails to open the drainage 
angle, laser iridoplasty may be considered as a treatment option and works by causing 
localised areas of shrinkage in the peripheral iris, causing it to be pulled away from the 
TM. Topical therapy may also be required as adjunctive treatment. Lens extraction with 
insertion of an intra-ocular lens (IOL) also causes widening of a closed/narrow drainage 
angle and is increasingly recognised to have a role in the management of angle closure 
glaucoma (18-20). 
 
1.2 Pigment dispersion syndrome 
 
Pigment dispersion syndrome (PDS) is an ocular condition predisposing to OHT. A 
proportion of patients with raised IOP will go on to develop a secondary OAG referred 
to as pigmentary glaucoma (PG). In 1949, Sugar and Barbour (21) reported 2 young, 
myopic men with Krukenberg spindles, iris transillumination defects and TM 
hyperpigmentation who developed raised IOP with mydriasis and decreased with 
pilocarpine, using the term ‘pigmentary glaucoma’ to describe the condition.  More 
patients were subsequently reported, and in 1966 Sugar reviewed 147 cases in the 
world literature(22), describing additional features including association with myopia, 
greater incidence in men than in women and a relatively young age of onset.  
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1.2.1  Clinical features 
 
PDS is characterised by the following triad: 
1. Krukenberg spindle. This is a central vertical band seen on the corneal 
endothelium and occurs as a result of aqueous convection currents depositing 
dispersed pigment on the endothelium. 
2. Mid-peripheral spoke-like iris transillumination defects, which can be seen by 
retro-illumination.  
3. Hyperpigmentation of the trabecular meshwork. This is usually a dense 
homogeneous band in a wide-open angle. With time pigment may regress 
initially from the superior trabecular meshwork, a phenomenon known as the 
pigment reversal sign (23). 
 
Other anterior segment features of the syndrome include: pigment particles on the 
anterior iris surface, anisocoria (larger pupil in eye with greater transillumination 
defect) (24), pigment at the insertion of lens zonular fibers into the posterior lens 
capsule (Zentmayer ring or Scheie stripe) (25), deeper anterior chamber depths than 
expected for age, sex and refractive error (26).   
 
Patients with PDS have been reported to have an increased prevalence of lattice 
degeneration reported to be 33% in a PDS cohort  and 20%  in a mixed PDS/PG cohort; 
these percentages are greater than expected for the degree for the degree of myopia 
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(27, 28). Prevalence of retinal detachment has been reported between 4-6.6% in PDS 
(28, 29) and 7.6% in PG (29) and these percentages are also greater than expected for 
the degree of myopia (29, 30). Greenstein et al. conducted electo-oculograms on 
patients with PDS and PG and reported significantly lower mean Arden ratios 
compared to control subjects and POAG/OHT patients, implicating the retinal pigment 
epithelium/photoreceptor complex in the pathology. Fundus autoflouresence imaging 
in the subjects with reduced Arden ratios would have been of interest in order to 
further investigate abnormalities of the posterior segment. 
 
1.2.2  Epidemiology 
 
PDS is more common in myopes (29, 31) with an approximately equal male to female 
ratio (23, 29) whilst PG is more common in men (29, 32, 33). Only one study has 
investigated the prevalence of PDS (34): a population glaucoma screening study of 654 
white subjects reported that 2.45% had evidence of PDS. 
 
1.2.3  Risk of conversion 
 
A study of 21 patients indicated that the probability of developing a significant IOP rise 
in PDS patients is 52% at 2 years (35) and 86% at 10 years (36). Several studies have 
investigated the risk of conversion from PDS to PG: Migliazzo et al.(33) conducted a 
retrospective study which included 37 PDS patients with OHT of whom 35 % eventually 
developed glaucomatous field defects (mean overall follow up period was 17 years). 
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Farrar et al. (30) conducted a similar retrospective study which included 18 patients 
with PDS. With regard to the latter group, 7 out of 18 (39%) converted to PG during the 
follow up period although this may be an underestimate as only 4 out of 18 had follow 
up of more than 6 months. Both of these studies included patients on treatment and 
were based on patients attending a specialist glaucoma service and as such are likely to 
include a disproportionate number of patients with OHT as referral from primary care 
of patients with PDS tends to be on the basis of high IOP. It is likely that there are many 
cases of PDS without OHT that are never referred to an ophthalmologist or glaucoma 
subspecialist. There has only been one community-based study looking at risk of 
conversion (32). The authors of this study conducted a retrospective review of 113 
patients with newly diagnosed PDS over a 24-year period and determined the 
probability of converting to PG to be 10% at 5 years and 15% at 15 years. 
 
1.2.4  Economic cost of pigmentary glaucoma 
 
Detection, treatment and provision of state and family social care for patients with 
primary POAG and OHT was estimated to cost £944 per patient for the year 2010 (37). 
Per patient costs are likely to be similar for PG. There are no prevalence data on PG but 
the incidence in a predominantly Caucasian population has been estimated at 1.4 per 
100,000. Using UK Census data for the size of the Caucasian population together the 
above estimates suggest the cost of newly diagnosed PG is £715,917 per year. The 
mean age of diagnosis is 42 years (compared to around 70 years in POAG) so the 
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lifetime costs after the first year of diagnosis are considerably more than POAG, not to 
mention the costs in lost productivity through visual disability in a population largely of 
working age. 
 
1.2.5  Pathophysiology 
 
Campbell (38) was the first to propose that in PDS the posteriorly bowed iris led to 
frictional contact between packets of anterior zonular fibres and the posterior pigment 
epithelium resulting in pigment dispersion. The concept of the ‘reverse pupillary block’ 
mechanism was introduced by Karickhoff (39). Karickhoff proposed that abnormal 
irido-lenticular contact causes the iris to act like a flap valve permitting unidirectional 
flow of aqueous from the posterior to the anterior chamber, maintaining the posterior 
bowing. Dispersed pigment is deposited throughout the anterior segment including 
within the TM. In a proportion of patients pigment accumulation in the TM leads to 
impaired drainage of aqueous humour with a consequent increase in IOP.  
 
Iris concavity in PDS/PG appears to be enhanced by accommodation and this has been 
quantified on studies using ultrasound biomicroscopy (UBM) (40) and AS-OCT (41). The 
degree of accommodation-induced concavity is inversely correlated with age (42). 
Accommodation is associated with miosis and forward movement of the anterior pole 
of the lens (43) which increases the area of irido-lenticular contact and potentiates the 
flap-valve effect. Accommodation-induced iris concavity appears, however, to be a 
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relatively transient response with reversal of concavity within 3 minutes despite 
continued accommodative effort (44). 
 
1.2.5.1  Damage to outflow 
 
Richardson et al. (45) conducted light and electron microscopy of TM from PDS 
patients and noted pigment granules entering TM undergo phagocytosis by endothelial 
cells. It was hypothesised that phagocytosis-induced damage to the endothelial cells 
led to denudation of the trabecular beams with subsequent collapse and sclerosis of 
TM. Alvarado et al. (46) determined that the majority of resistance to aqueous outflow 
occurs at the terminations of the aqueous channels (cul-de-sacs) and have shown the 
area of these terminations to be markedly reduced in TM specimens from PG and 
POAG patients compared to those from non-glaucomatous normal subjects. 
 
1.2.6  Management  
 
1.2.6.1  Topical therapy 
 
Topical drugs can be used to manage raised IOP in OAG and the same classes of drug 
are also used to manage raised IOP secondary to pigment dispersion. Prostaglandin 
analogues, beta-blockers, carbonic anhydrase inhibitors and alpha-adrenergic agonists 
can all lower IOP. Pilocarpine, a parasympathomimetic acting on cholinergic receptors, 
reduces IOP by increasing outflow and has the additional advantage of reducing iris 
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concavity (41, 47). However in practice, high concentrations of pilocarpine are often 
poorly tolerated in young myopes on account of causing increased myopia and 
accommodative spasm. Furthermore, pigment dispersion subjects require a careful 
peripheral retinal examination prior to commencing miotic therapy as this class of 
drugs is associated with an increased risk of retinal detachment (48). 
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1.2.6.2  Laser trabeculoplasty 
 
ALT appears to be effective early on in PG with a subsequent increase in IOP after 3 
months(49). Longer-term ALT success rates have been reported between 62-80 % at 8-
12 months (50, 51) with younger patients and those with glaucoma of a shorter 
duration having greater success rates. 
 
A study of 30 eyes with PG (52) reported success rates with SLT at 85% at 12 months 
but only 14% at 48 months. Criteria for classifying a treatment as failed were, however, 
quite stringent: <20% drop in IOP, subsequent change in medical treatment, 
performance of a further SLT treatment or the need for surgery. There are conflicting 
data on the safety of SLT in PDS/PG. In the above study (52), the authors reported 2 
cases showing mild inflammation following laser and a further 2 cases developing IOP 
spikes 2 hours post laser, which normalised the following day. Kouchecki et al. (53) 
reported a mean reduction in IOP of 19% at 18 months although 26% needed either 
further SLT or trabeculectomy and 22% developed significant IOP spikes. 
Harasymowycz et al. (54) noted significant IOP spikes following SLT in heavily 
pigmented in eyes of 4 patients (3 of whom had features of pigment dispersion); 3 of 
these eyes went on to require trabeculectomy. The authors suggested that eyes with 
heavily pigmented TM, previous ALT and being on multiple topical medications are 
potential risk factors for IOP spikes. 
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1.2.6.3  Role of laser peripheral iridotomy 
 
Laser peripheral iridotomy (LPI) is a widely established procedure for primary angle 
closure and angle closure glaucoma. It is generally regarded as a safe procedure 
although there is a small short-term risk of bleeding, raised IOP and inflammation; such 
adverse effects are generally transient and can usually be managed without resulting in 
significant long-term sequelae. Diplopia or ‘ghost images’, lens opacity and corneal 
injury are rare complications and malignant glaucoma, retinal burns and lens-induced 
uveitis are extremely rare complications. 
 
Performing LPI in PDS/PG patients provides a route by which aqueous humour can 
drain from the anterior to the posterior chamber, thereby overcoming reverse 
pupillary block and reducing or eliminating iris concavity. A reduction in iridolenticular 
contact and iris concavity following LPI have been reported in UBM studies (48-50). LPI 
may therefore reduce the amount of pigment dispersed and represents a one-off, 
relatively non-invasive intervention with the potential to reduce the risk of developing 
raised IOP and PG.  
 
Gandolfi et al. (27) investigated the effect of LPI in eyes with normal IOP at baseline. 
The authors reported results on 21 PDS subjects (age range 18-60 years) who 
underwent unilateral LPI in a randomly selected eye whilst the fellow untreated eye 
served as the control. At 2 years, 52% of untreated eyes showed an elevation of 
5mmHg or more compared with only 4.7% of treated eyes. LPI appeared less effective 
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in older patients. Scott et al. (55) conducted a prospective randomized control trial of 
116 patients with PDS and ocular hypertension. Eight eyes (15%) in the laser group and 
3 eyes (6%) in the control group converted to glaucoma in the study period (median 
follow up 3 years). Studies have also investigated the effect of LPI in PDS patients with 
raised pressure and PG: Reistad et al. (56) retrospectively analysed data contributed by 
members of the American Glaucoma Society on patients with bilateral PG receiving 
uni-ocular LPI. A greater decrease in IOP was observed in treated eyes compared with 
fellow eyes (among 46 patients observed for 2 years or more), however, linear model 
analysis indicated that the higher mean baseline IOP in the treated eyes accounted for 
the apparent treatment effect. Lagreze et al. (53) reported on IOP pre- and post-LPI in 
their cohort of 20 PDS (including some PG) eyes and found no significant difference at 
9 months when compared with untreated fellow eyes. There is little data, therefore, to 
support the efficacy of LPI in eyes that have already developed an IOP rise or GON. 
 
1.2.6.4  Trabeculectomy 
 
Filtering surgery is required in cases of PG where topical or laser therapy has been 
insufficient to control IOP. PG patients tend to be young and are therefore at risk of 
bleb failure from excessive post-operative scarring and the use of anti-metabolite 
adjuncts such as MMC is particularly useful to modulate the post-operative course. A 
large clinical study suggested that a greater percentage of PG patients require 
trabeculectomy compared to a randomly selected control group with chronic simple 
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glaucoma and that men with PG required surgery at a younger age compared to 
women with PG (29).  
 
1.2.7  Pigment dispersion as a heritable phenotype 
 
Becker(57) et al. originally proposed that PDS had a specific genetic pre-disposition 
when they noted an increased prevalence of HLA B13 or Bw17 in PDS subjects 
compared to those without PDS, although this finding was not replicated in a small 
subsequent study (58). Gramer et al. (59) report a family history of glaucoma in 39% of 
patients with PDS or PG, but such a family history was no more common in PG 
compared to PDS. There are several reports of families segregating for PDS/PG (60-62).  
 
1.2.7.1  Gene mapping in PDS/PG families 
 
Linkage analysis is the method of choice for gene mapping in large multigenerational 
families in which at least 4 individuals are affected. The approach identifies disease 
susceptibility loci by typing genetic markers across the genome in the most informative 
members of the family and studying which markers are linked with the disease of 
interest. Linkage analysis was used by Andersen et al. (63) who studied 4 families 
segregating for PDS/PG, all of whom had some degree of Irish ancestry, and reported 
significant linkage to the telomere of the long arm of human chromosome 7 (7q35-
q36), a locus subsequently designated as GPDS1 (glaucoma-related pigment dispersion 
syndrome 1, OMIM ID 600510). Based on this region, a homeobox gene involved in 
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forebrain development, a cholinergic receptor gene and a gene for nitric oxide 
synthetase were put forward as candidate genes. Mutations in nitric oxide synthetase 
could lead to the production of reactive nitrogen species, possible mediators of 
apoptotic cell death within iris tissue or cells of the RPE/photoreceptor complex. A 12 
cM region located within 18q21 was subsequently identified as a second locus through 
linkage analysis on 4 further pedigrees (64) although no causative genes have so far 
been identified from either locus. Subsequently, polymorphisms of the GPDS1 locus 
have been shown to be associated with normal tension glaucoma in a Japanese 
population (65). 
 
Ritch (23) highlighted that a causative gene would need to explain the increased 
prevalence of lattice degeneration and suggested the gene would affect development 
of the middle third of the eye early in the third trimester as this would be consistent 
with a condition that appears to affect the iris as well as the retina.  
 
1.2.7.2  DBA/2J mouse model 
 
John et al.(66) described pigment dispersion and iris atrophy in mice of the inbred 
strain DBA/2J. DBA denotes the parent strain, ‘2’ denotes the sub-strain and ‘J’ refers 
to the Jackson Laboratory where the strain was developed. IOP was increased in this 
strain by around 9 months of age with subsequent retinal ganglion cell death, optic 
nerve atrophy and optic nerve cupping. There are, however, important differences 
between the clinical findings in DBA/2J mice and PG in humans: in the mouse model 
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there is accumulation of macrophages laden with pigment in the angle and a tendency 
to develop both anterior and posterior synechiae leading to secondary angle closure 
rather than the OAG seen in human PG. In addition, the presence of iris atrophy and 
anterior synechiae suggest a degree of overlap with the irido-corneal endothelial (ICE) 
syndrome. The pigment dispersion in this strain was subsequently found to be caused 
by a premature stop codon mutation in a gene known as Gpnmb (67), occurring only in 
strains homozygous for this change whilst stromal atrophy was caused by the recessive 
allele of Tyrp1 (67).  
 
Schraermeyer et al. (68) used light and electron microscopy and 
immunohistochemistry to study the ocular pigment abnormalities in the DBA/2J strain. 
The authors reported migration of macrophages from the iris into the TM where they 
block aqueous outflow.  These macrophages are laden with immature melanosomes 
(melanin-containing granules within melanocytes) from the iris pigment epithelium and 
the authors commented that abnormal melanosomes were also present in the iris of 
some PDS patients.  
 
1.2.7.3  Myocilin and pigmentary glaucoma 
 
The published literature on the genetics of PDS has thus far failed to separate out 
distinct genetic contributions to PDS and the glaucomatous optic neuropathy (GON) 
that may ensue. Some investigators have suggested that PG may be a variant of POAG 
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(69) and it may be that there are separate genetic components independently 
conferring susceptibility to PDS, and raised IOP/GON. 
 
PDS and PG have been associated in several studies with mutations in the myocilin 
(MYOC) gene, one of the few genes whose causative role in glaucoma is well-
established. MYOC was originally discovered by Stone et al.(70) who reported 
mutations in in this gene causing juvenile open angle glaucoma (JOAG); the gene 
mapped to the GLC1A region which had been previously identified by Sheffield et 
al.(71) through linkage analysis of large pedigree segregating for autosomal dominant 
JOAG.  
 
MYOC encodes a 504-amino-acid glycoprotein, which contains an olfactomedin domain 
(residues 246–501), where the majority of the mutations documented have been 
identified, although the exact role of myocilin in the pathogenesis of OAG is unknown. 
Over 70 mutations in the MYOC gene have been implicated in POAG (72) and MYOC 
mutations are thought to be responsible for 2-4% of glaucoma worldwide (73). MYOC 
associated OAG is particularly associated with high IOP (74). Whilst MYOC mutations 
were initially associated with JOAG, the most common mutation, Gln368Stop, is 
associated with late-onset OAG (75, 76).   
 
A small number of mutations in MYOC have been reported in associated with PDS/PG. 
Vincent et al. (77) have reported Thr293Lys mutation in a 31 year old with PG. The 
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proband had a family history of late onset POAG but this remained unconfirmed as 
family members were not available for examination. Faucher et al.(78) reported a 40 
year with PG carrying the Ala445Val MYOC mutation and Alward et al. (79) reported a 
case of PG associated with Arg470Cys and a case of pigment dispersion (without 
glaucoma) carrying the Gln368Stop mutation. Conversely, Paglinauan et al. (80) have 
described 3 pigment dispersion pedigrees where linkage to the 1q21-q31 region (the 
locus subsequently found to contain MYOC) was excluded. 
 
1.3 Aims 
 
Whether to perform LPI in patients with PDS/PG remains an area of controversy and 
depends, to a large extent, on whether iris concavity is the key abnormality driving the 
pathogenesis of the condition. As LPI represents a relatively non-invasive, one-off 
intervention with the potential to prevent the development of glaucoma (and thereby 
avoid the necessity of lifelong drops and possible filtering surgery) in a relatively young 
patient population, establishing the role of iris concavity in pigment dispersion 
syndrome remains a goal of considerable importance. 
 
Establishing the genetic basis of PDS/PG is important for 2 main reasons: 1) it might 
allow screening of unaffected first degree relatives of patients, allowing those without 
genetic predisposition to be safely discharged to the care of their optometrist whilst 
focusing resources on those carrying high risk mutations in an effort to commence 
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treatment prior to the onset of significant visual loss, and, 2) understanding the 
molecular pathways underlying the pathogenesis could lead to the discovery of targets 
for novel therapies. 
 
Within this context, the work has 3 principal aims: 
1) To determine which anterior segment parameters, as quantified on AS-OCT, best 
distinguish PDS/PG eyes from age-, sex- and refraction-matched controls 
2) To determine the prevalence of iris concavity in early adolescence and explore 
associations with refractive error 
3) To identify disease susceptibility loci/genes for PDS/PG using 2 different 
approaches: linkage analysis in a pedigree segregating for PDS/PG and genome-
wide analysis in a cohort of unrelated PDS/PG probands using an appropriate 
genotypic control dataset 
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2.1 Introduction 
 
Iris concavity (IC) is considered to be the key anatomical abnormality in PDS and 
reversal of this concavity is the basis for offering patients laser peripheral iridotomy 
(LPI). 
 
2.1.1  Quantification of iris concavity and the role of accommodation  
 
The role of IC in PDS has been studied with ultrasound biomicroscopy (UBM). Carassa 
et al. (81) have described a method for IC quantification by measuring the maximum 
deflection of the posterior iris pigment epithelium from a line constructed between the 
innermost point of the posterior pigment epithelium in contact with the lens and its 
outermost point at the iris root. The authors reported IC in 27 of 50 PDS eyes and in 2 
out of 15 control subjects. Of the 23 eyes with PDS showing either a convex or planar 
configuration, 3 showed concavity on accommodation only.  Studies that have 
specifically investigated the role of accommodation in iris concavity in PDS/PG have 
yielded conflicting results. Adam et al. (42) studied the changes in iris profile in 92 
patients with PG and reported the accommodated state to be associated with 
significant posterior bowing. Balidis et al. (82) studied 49 eyes of 30 PDS/PG subjects 
and found the effect of accommodation on iris profile to be variable, reporting an 
increase in concavity in only 20% of subjects on accommodation. However, the mean 
age of the subjects in the latter study was 53 years, which was 11 years older than the 
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mean age of the study by Adam et al. which might account of the apparent difference 
in accommodation-induced concavity 
 
2.1.2  Iris concavity and blinking 
 
Liebmann et al. (83) have demonstrated, using UBM, how prevention of blinking alters 
iris configuration. After a period of up to 15 minutes of continuous scanning, during 
which time blinking was prevented, the authors reported anterior iris movement in 10 
out of 10 PDS eyes and 9 out 10 healthy controls. The mean change in iris position, 
from most concave to most convex was 0.32 mm for eyes with PDS and 0.09 mm for 
control eyes (P=0.0001). It is thought that when blinking is prevented, aqueous humour 
accumulates in the posterior chamber. Normal blinking produces transient vector 
forces on the cornea which promote aqueous flow from the posterior to the anterior 
chamber leading to a more concave (or less convex) configuration.  
 
2.1.3  Anterior segment biometry in PDS/PG compared to controls 
 
Investigators have reported greater anterior chamber depth in PDS/PG subjects 
compared with other forms of open angle glaucoma or glaucoma suspects (84) and a 
more posterior iris insertion (85) compared to matched controls. To identify the 
anatomical factors predictive of PDS, Mora et al. (86) conducted a study examining iris-
lens contact, iridocorneal angle and iris concavity as measured by UBM comparing 24 
PDS/PG subjects with 25 age-, sex- and refraction-matched controls. Receiver 
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operating characteristic (ROC) curves were constructed to assess the ability of UBM to 
discriminate between cases and controls. Irido-corneal angle in accommodation was 
found to be the most sensitive parameter, reaching a sensitivity and specificity of 0.875 
with a cut off of 53˚. Interestingly, IC in accommodation was the 2nd most sensitive 
parameter. 
 
2.1.4  Anterior segment optical coherence tomography in PDS/PG 
 
Whilst UBM has advanced our understanding of iris configuration in PDS, it does 
require physical contact with the globe with the patient in a supine position. 
Furthermore, the ultrasound probe in contact with the patient’s eye is likely to reduce 
the blink rate and this may lead to underestimates of the degree of iris concavity; this 
departure from the physiological state gives rise to the potential for artefactual results. 
Anterior segment optical coherence tomography (AS-OCT) is a non-contact imaging 
device that images the eye with the patient sitting upright and may better reflect true 
iris anatomy. Laemmer et al. (87) reported iris concavity in 18 out of 22 PDS subjects 
but also mild iris concavity in 1 out of 10 control patients using AS-OCT. Liu et al. (41) 
used AS-OCT to study iris contour in 20 PDS subjects and their data corroborated the 
conclusions of Adam et al. (42) in supporting the role of accommodation in inducing iris 
concavity. However, in contrast to the UBM studies, they reported that the iris 
concavity diminished when blinking was allowed; even a subsequent phase of forced 
blinking did not restore iris concavity. One disadvantage of AS-OCT, however, is its 
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inability to image structures posterior to the iris (88) meaning it is unable to reliably 
quantify areas of irido-lenticular contact. 
 
2.1.5  Repeatability of iris curvature measurements 
 
Balidis et al. (89) have investigated the repeatability of iris curvature measurements by 
UBM in PDS/PG and concluded that whilst there was good intra-observer agreement, 
the variability between observers was greater and suggested that when using their 
method of measuring iris concavity, measurements should preferably be taken by the 
same observer. 
 
Although AS-OCT is now becoming more commonly used to image iris anatomy in PDS 
(74, 87), there are no published data investigating the repeatability of this modality in 
assessing iris concavity. The first part of this chapter describes a study assessing 
between- and within-observer agreement in measuring iris curvature in AS-OCT images 
of patients with PDS/PG. 
 
2.1.6  Case-control study 
 
The majority of studies examining differences between PDS/PG subjects have used 
UBM to image the anterior segment (84-86). AS-OCT allows a more physiological 
record of anterior segment biometry to be obtained and in particular allows for 
assessment of features such as iris curvature, anterior chamber depth and relative iris 
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insertion, all of which are thought to be significantly different in PDS/PG subjects 
compared with matched controls. The second part of this chapter describes a case-
control study where AS-OCT biometric parameters of 50 PDS/PG subjects and 50 age-, 
sex- and refraction-matched controls were compared. The purpose of this study was to 
determine the relative importance of each parameter in distinguishing PDS/PG from 
myopic control subjects and to validate findings of previous UBM-based studies. 
Differences in iris curvature between cases and controls is of particular interest as the 
intervention of LPI is thought to work by reducing iris concavity and eliminating the 
anatomical predisposition to pigment dispersion. 
 
2.2 Methods 
 
Participants recruited into a genetic study into PDS/PG were enrolled between 
December 2008 and July 2011. Participants underwent detailed phenotyping 
comprising slit lamp biomicroscopy looking for the presence of Krukenberg spindle and 
iris transillumination defects and gonioscopy to document the presence and amount of 
trabecular meshwork hyperpigmentation. IOP was checked using Goldmann 
applanation tonometry and optic disc assessment was performed using indirect 
ophthalmoscopy. Automated perimetry was performed with the Humphrey Field 
Analyzer Mark II (or II-i) and the Swedish interactive threshold algorithm standard 24-2 
program. Refractive error was determined by spectacle focimetry or autorefraction if 
current spectacles were not available. Ethics Committee approval was obtained and 
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the study adhered to the tenets of the Declaration of Helsinki, a statement of ethical 
principles for medical research involving human subjects, including research on 
identifiable human material and data. 
As part of the phenotyping for this study participants underwent AS-OCT imaging and 
provided informed consent for the purposes of the imaging studies. Diagnostic criteria 
for PDS were a) at least 270° of confluent dark brown trabecular meshwork 
pigmentation plus either a Krukenberg spindle or mid-peripheral transillumination 
defects, or b) 180 dark brown trabecular meshwork pigmentation plus both 
Krukenberg spindle and mid-peripheral transillumination defects.  A diagnosis of PG 
was made if, in addition, there was a glaucomatous visual field defect on automated 
24-2 Humphrey perimetry with corresponding damage to the optic nerve head (cup-to-
disc ratio ≥ 0.07, focal narrowing of the neuroretinal rim, or both). Subjects with 
previous intra-ocular surgery , LPI or non-glaucomatous causes of field loss were 
excluded. 
 
2.2.1  Image acquisition 
 
Anterior segment imaging was performed using the Visante AS-OCT (Carl-Zeiss-
Meditec, Dublin, California, USA). Images were acquired using near and distance 
fixation targets in dim illumination with the room lights switched off and window blind 
pulled down prior to image acquisition. Fixation was monitored using the pupil-tracking 
screen and the appearance of a central interference flare was used to indicate good 
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centration. A scan of the temporal and nasal quadrants was taken using the ‘horizontal 
scan’ protocol; as the focimetry/autorefraction details had been entered during the 
registration process, this scan was deemed to represent distance fixation. 
 
The "POWER" tab, which controls the focus of the fixation target and is set by default 
to zero, was gradually reduced while asking the subject if he could still see a clear and 
sharp image. The value at which the subject reported a blurred image was noted e.g. -
3.00 dioptres. The subject was moved away and the power value determined above 
was exceeded e.g. -4.00 dioptres before placing the subject back onto the chin rest. 
The power value was then made gradually more positive, acquiring the image once the 
subject reported seeing a sharp image again. This second scan was deemed to 
represent near fixation. 
 
2.2.2  Line construction for iris concavity 
 
A line was drawn from the innermost to the outermost extremity of the posterior 
pigment epithelium (figure 2.1a). At the point of maximal iris deflection, a second line 
was constructed starting from, and perpendicular to, the first line. This line was 
extended to the posterior iris pigment epithelium and its length was taken as the iris 
deflection measurement (figure 2.1b). Blinking was allowed during image acquisition 
and the iris deflection measurement was taken in the same way regardless of whether 
the accommodation has been induced. 
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Figure 2.1a  Line joining inner and outer extremities  
 
 
Figure 2.1b  Measuring maximum deflection. In this example iris concavity was recorded as -0.35 
mm. 
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2.2.3  Between- and within-observer agreement study 
 
AS-OCT images from the first 50 consecutive PDS/PG patients were used for this study. 
The eye with the least flat iris profile was selected from each eye pair to maximize the 
chance of finding disagreement between and within observers. Iris curvature was 
quantified independently by 2 observers for both temporal and nasal quadrants using 
AS-OCT software as described in section 2.2.2. A small number of examples were 
discussed amongst the observers with the aim of achieving uniformity in identifying the 
scleral spur. These examples were not included in the analysis. Observer 1 repeated 
the measurements on the same set of images 1 week later. Nasal and temporal 
quadrants were analysed separately. Bland-Altman plots were constructed. Average 
agreement (bias) was estimated by the mean of the differences between or within 
observers and limits of agreement (LoA) were calculated as the bias +  (1.96 x standard 
deviation of the differences) (90). 
 
In addition to quantitative measurements, iris profiles were categorised as planar                   
(-1.0 ≤ deflection ≤ 1.0), convex (deflection > 1.0) or concave (deflection < -0.1). 
Agreement was assessed using a weighted Kappa statistic (). Statistical analyses were 
performed using MedCalc Version 11.2.1.0. 
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2.2.4   Anterior segment imaging case-control study 
 
2.2.4.1   Control subjects 
 
The ‘case’ group comprised 50 PDS/PG subjects recruited as part of the genetic study.  
A ‘control’ cohort was recruited from members of staff at Moorfields Eye Hospital and 
patients without PDS who were attending the Glaucoma Service for management of 
primary open angle glaucoma, ocular hypertension or who were glaucoma suspects. 
Control subjects underwent similar clinical examination and each subject was matched 
to a PDS/PG subject, based on: 1) sex, 2) age within 5 years and 3) spherical equivalent 
(SE) as judged by spectacle focimetry or autorefraction within 1 dioptre. Cases and 
controls were both predominantly of Caucasian ancestry which mimimised differences 
in ethnicity between the groups giving rise to bias. 
 
2.2.4.2   Additional AS-OCT analysis 
 
In addition to iris curvature, the following additional analysis was performed on the 
non-accommodative and accommodative images from both the case and control 
cohort using the device’s in-built software (Visante version 3.0). The scleral spur was 
identified by the operator and based on this landmark the software calculated the 
following parameters: anterior chamber depth (ACD), scleral-spur to scleral-spur 
distance, lens vault (LV, the perpendicular distance between the anterior pole of the 
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crystalline lens and a horizontal line joining the 2 scleral spurs (91)), angle opening 
distances at 500 and 750 microns from scleral spur (AOD500 and AOD750) (92) and 
trabecular-iris space area (TISA) at 500 and 750 microns from the scleral spur (TISA500 
and TISA750) (93). These measurements are illustrated in figure 2.2. 
 
The antero-posterior distance between the scleral spur and the iris root (abbreviated 
to ‘root-to-spur’ from this point forward) is an important metric as greater proximity of 
the iris root to the scleral spur implies the posterior iris pigment epithelium is 
anatomically closer to the lens zonules resulting in a greater likelihood of frictional 
contact. The root-to-spur distance was measured as follows (figure 2.3): the calliper 
tool was used to construct a straight line joining the nasal and temporal scleral spur.  
The posterior iris pigment epithelium is well defined on AS-OCT as a line of hyper-
reflectivity and the iris root insertion was defined as the point where this line 
terminates peripherally. A second line was then constructed starting at the iris root 
insertion running parallel with the first line. The root-to-spur distance was deemed to 
be the perpendicular distance between these 2 parallel lines.  
 
2.2.4.3   Statistical analysis 
 
The means of the above parameters were compared between cases and controls using 
a paired Student t-test. Receiver operating characteristic (ROC) analysis was used to 
assess the ability of each of the measured parameters in distinguishing PDS/PG cases 
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from controls. Comparison of the areas under the ROC curves (AUC) was calculated 
according to DeLong et al. (94). Correlations between iris curvature and age were 
explored using Pearson’s correlation coefficient. A previously published cut-off(86) was 
tested in the present cohort. Analyses were performed using MedCalc Version 11.3.1.0 
and Prism version 6.0c for Mac OS X, GraphPad Software, La Jolla California USA, 
www.graphpad.com. A P-value < 0.05 was deemed significant. 
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Figure 2.2 Example AS-OCT screenshot illustrating semi-automated measurements. White arrow 
denotes scleral spur. Yellow and green arrows denote points 500 μm and 750 μm 
respectively anterior to scleral spur along corneal endothelium. 
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Figure 2.3 Determination of posterior displacement of iris root from scleral spur. A. Identification 
of scleral spur (long arrow) and iris root (short arrow). B. Construction of horizontal line 
joining scleral spurs and parallel line originating at iris root. C. Displacement deemed to 
be perpendicular distance between horizontal lines measured at iris root. In this 
example displacement is 0.67 mm in the temporal quadrant and 0.47 in the nasal 
quadrant. 
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2.3 Results 
 
2.3.1  Between- and within-observer agreement  
  
Images from one subject were of insufficient quality to confidently measure iris 
curvature and these were excluded from the analysis. Tables 2.1 and 2.2 show results 
of within- and between-observer agreement for classifying temporal quadrant images 
as convex, flat or concave. Results for nasal quadrant were similar (data not shown). 
 
 Observer 1(A) 
Concave Flat Convex 
Observer 1(B) concave 20 1 0 
flat 1 11 0 
convex 0 1 15 
Weighted kappa statistic = 0.96 
Table 2.1  Within-observer agreement for classifying temporal quadrant 
 
 Observer 1 
Concave Flat Convex 
Observer 2 concave 14 1 0 
flat 4 13 0 
convex 0 1 17 
Weighted kappa statistic = 0.89 
Table 2.2  Between-observer agreement for classifying temporal quadrant 
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Bland-Altman plots showing within- and between-observer agreement are shown in 
figures 2.4 and 2.5 respectively. Neither of these plots showed any relationship 
between the measurement difference and the magnitude of the measurement and it 
was therefore appropriate to calculate 95% limits of agreement (LoA) which are shown 
in table 2.3. 
 
Difference Bias (mm) 95% LoA (mm) 
Between-observer temporal quadrant -0.008 -0.056 to 0.040 
Between-observer nasal quadrant -0.009 -0.065 to 0.048 
Within-observer temporal quadrant 0.005 -0.057 to 0.067 
Within-observer nasal quadrant -0.003 -0.039 to 0.034 
Table 2.3 Bias and 95% limits of agreement (LoA) for between- and within-observer difference in 
estimate of iris concavity  
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Figure 2.4 Bland-Altman plot to show within-observer agreement in the temporal quadrant 
 
 
Figure 2.5  Bland-Altman plot to show between-observer agreement in the temporal quadrant 
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2.3.2  Anterior segment imaging case-control study 
 
Fifty eyes of 50 patients were imaged from each of the case and control group. The 
accommodative scan was not available for 1 PDS case. The posterior pigment 
epithelium was poorly visible in 1 control patient and the scleral spur could not be 
identified in another control patient.  
 
The mean subject age was 41.9 years in both the case and the control group. The mean 
SE was -2.1 D in the case group and -2.25 D in the control group; this difference was 
not statistically significant (P = 0.36). There was no statistically significant difference in 
spur-to-spur distance between the 2 groups. The mean anterior lens movement on 
accommodation was 76.1 μm in the PDS group compared to 90.8 μm in the control 
group (P = 0.143, paired Student t-test). Statistically significant differences between 
cases and controls were seen for all other AS-OCT parameters (table 2.4), data not 
shown for AOD750 and TISA750 but differences between cases and controls were 
similar to AOD500 and TISA500 respectively). The area under the ROC curve for these 
parameters is shown in table 2.5 (data not shown for AOD750 and TISA750 but AUC 
was similar to AOD500 and TISA500 respectively).  
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Table 2.4  Summary of anterior segment optical coherence tomography parameters in cases and 
controls. NA = non-accommodating, A = accommodating, AC = anterior chamber, AOD 
= angle-opening distance; TISA = trabecular-iris space area. In the case group, N=50 for 
non-accommodative measurements and N=49 for accommodative measurements. In 
the control group, N=49 for both accommodative and non-accommodative 
measurements. 
  
Parameter Case (SD) Control (SD) Mean 
difference 
Test 
statistic t 
Two-tailed 
probability 
Mean AC depth NA 
/mm 
3.17(0.39) 2.94(0.51) -0.23 -2.95 0.0049 
Mean AC depth 
A/mm 
3.07(0.33) 2.89(0.30) -0.18 -3.09 0.0034 
Mean lens vault 
NA/ μm 
-5.0(308.1) 176.2(252.6) 181.2 3.53 0.0009 
Mean lens vault A/ 
μm 
77.96(244.17) 276.73(235.20) 198.8 4.320 0.0001 
Mean AOD500 
NA/mm 
0.831(0.440) 0.485(0.233) -0.346 -4.89 <0.0001 
Mean AOD500 
A/mm 
0.823(0.426) 0.494(0.238) -0.329 -4.756 <0.0001 
Mean TISA500 
NA/mm
2 
0.296(0.174) 0.170(0.091) -0.127 -4.613 <0.0001 
MeanTISA500 
A/mm
2
 
0.282(0.149) 0.494(0.238) -0.212 5.398 <0.0001 
Mean angle NA/° 54.5 (14.6) 41.3(13.3) -13.2 -4.500 <0.0001 
Mean angle A/ ° 53.1(16.4) 41.9(13.7) -11.3 -3.475 0.0011 
Mean spur-to-root 
distance NA/mm 
0.570(0.135) 0.481(0.164) -0.089 -2.788 0.0076 
Mean spur-to-root 
distance A/mm 
0.530(0.116) 0.416(0.164) -0.114 -3.987 0.0003 
Mean iris curvature 
NA/mm 
-0.029(0.223) 0.149(0.119) 0.177 5.185 <0.0001 
Mean iris curvature 
A/mm 
-0.070(0.236) 0.113(0.415) 0.183 2.573 0.0133 
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Parameter AUC 95% CI P value* Criterion Sensitivity 
(%) at 90% 
specificity 
AC depth NA/mm 0.613 0.511-0.709 0.0453 >2.68 28.0 
AC depth A/mm 0.649 0.546-0.742 0.0072 >3.09 26.5 
Lens vault NA/μm 0.675 0.574-0.765 0.0011 ≤30 30.0 
Lens vault A/ μm 0.742 0.645-0.825 0.0001 ≤100 22.5 
AOD500 NA/mm 0.762 0.666- 0.841 0.0001 >0.6 45.0 
AOD500 A/mm 0.743 0.645-0.826 0.0001 >0.637 32.7 
TISA500 NA/mm 0.756 0.660-0.837 0.0001 >0.201 45.0 
TISA500 A/mm 0.729 0.630-0.813 0.0001 >0.203 31.6 
Angle NA/° 0.760 0.664-0.840 0.0001 >50.1 46.0 
Angle A/° 0.724 0.625-0.809 0.0001 >49.3 30.6 
Spur-to-iris root 
distance NA/mm 
0.648 0.545-0.741 0.0085 >0.43 12.0 
Spur-to-iris root 
distance A/mm 
0.723 0.623-0.808 0.0001 >0.42 10.2 
Iris curvature 
NA/mm 
0.817 0.727-0.888 0.0001 ≤0.08 58.4 
Iris curvature 
A/mm 
0.700 0.599-0.789 0.0001 ≤0 30.6 
Table 2.5 Receiver Operating Characteristic analyses for anterior segment optical coherence 
tomography parameters in cases and controls. NA = non-accommodating, A = 
accommodating, AC = anterior chamber, AOD = angle-opening distance; TISA = trabecular-iris 
space area AUC = area under the curve. *Testing the hypothesis that AUC = 0.5 
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The best performing parameter at distinguishing between cases and controls was iris 
curvature in non-accommodating eyes. The area under the ROC curve was 0.82 (95% CI 
0.73-0.89, P = 0.0001) and this area was significantly greater than the areas under the 
curve for non-accommodating AC depth, accommodating AC depth and 
accommodating iris curvature (P =  0.001, 0.004 and 0.01 respectively). Comparison of 
the ROC curve for non-accommodating iris curvature with those for accommodating 
iris curvature and anterior chamber angle can be seen in figure 2.6 and comparison 
with LV and root-to-spur distance can be seen in figure 2.7. 
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Figure 2.6  Receiver operating characteristic curves for iris curvature and anterior chamber angle. 
NA = non-accommodating, A = accommodating. 
 
 
 
 
 
 
 
Figure 2.7  Receiver operating characteristic curves for iris curvature, lens vault and spur-to-root 
distance. NA = non-accommodating, A = accommodating. 
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AUC was in fact similar for all parameters and a correlation matrix was constructed to 
investigate the relationship between the AS-OCT parameters (tables 2.6 and 2.7). The 
angle-derived parameters (angle, AOD500/750 and TISA500/750) were all strongly 
correlated with each other (r = 0.89 - 0.99), LV and ACD were moderately correlated 
with angle-derived parameters (r = 0.36 – 0.60) whilst iris curvature was the most 
weakly correlated (r = 0.26 – 0.42). A scatter plot of age against accommodative iris 
curvature is shown in figure 2.8. Regression analysis was performed for iris curvature 
on age (table 2.8). Robust regression with outlier exclusion (95) revealed that age 
accounts for a significant amount of variation in accommodative iris curvature in both 
cohorts. The association remained significant but was weaker for non-accommodative 
iris curvature. A previously published cut-off to distinguish between PDS/PG and 
control eyes of 53˚angle width, derived from UBM measurements, (86) was tested in 
our cohort and correctly classified 27 out of 50 cases of PDS/PG (54% sensitivity) and 
38 out of 50 controls (76% specificity). 
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Figure 2.8 Scatterplot of accommodative iris curvature against age in PDS/PG cohort 
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Group Outlier 
exclusion 
r
2
 
 
P value 
PDS/PG NA no 0.25 0.002 
PDS/PG NA yes 0.16 0.003 
PDS/PG A no 0.29 <0.0001 
PDS/PG A yes 0.44 <0.0001 
Controls NA no 0.09 0.038 
Controls NA yes 0.10 0.026 
Controls A no 0.07 0.065 
Controls A yes 0.51 <0.0001 
Table 2.8 Results of robust regression of iris curvature on age with and without outlier exclusion. 
A = accommodating, NA = non-accommodating. PDS/PG = pigment dispersion 
syndrome/pigmentary glaucoma 
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 AC 
depth/
mm 
Lens vault 
/μm 
AOD500/ 
mm 
AOD750/ 
mm 
TISA500/ 
mm 
TISA750/ 
mm 
Angle/° 
Spur-to-iris root 
distance /mm 
Iris 
curvature 
AC depth/mm 1.0 -0.40 0.40 0.46 0.36 0.60 0.41 0.26 -0.37 
Lens vault /μm -0.40 1.0 -0.51 -0.51 -0.44 -0.54 -0.54 -0.25 0.25 
AOD500/mm 0.40 -0.51 1.0 0.95 0.96 0.99 0.96 0.70 -0.33 
AOD750/mm 0.46 -0.51 0.95 1.0 0.89 0.95 0.93 0.68 -0.38 
TISA500 /mm 0.36 -0.44 0.96 0.89 1.0 0.98 0.89 0.74 -0.26 
TISA750 0.60 -0.54 0.99 0.95 0.98 1.0 0.99 0.78 -0.42 
Angle/° 0.41 -0.54 0.96 0.93 0.89 0.99 1.0 0.68 -0.37 
Spur-to-iris root distance/mm 0.26 -0.25 0.70 0.68 0.74 0.78 0.68 1.0 -0.15 
Iris curvature/mm -0.37 0.25 -0.33 -0.38 -0.26 -0.42 -0.37 -0.15 1.0 
Table 2.6 Correlation matrix to show correlation between non-accommodating anterior segment optical coherence tomography parameters. All values 
represent Pearson correlation coefficient, apart from correlations between TISA750 and other parameters for which Spearman’s rank 
correlation is shown. ACD, anterior chamber depth; AOD, angle-opening distance; TISA, trabecular-iris space area. 
 
 
 AC 
depth/
mm 
Lens vault 
/μm 
AOD500/ 
mm 
AOD750/ 
mm 
TISA500/ 
mm 
TISA750/ 
mm 
Angle/° 
Spur-to-iris 
root distance 
/mm 
Iris 
curvature 
AC depth/mm 1.0 -0.16 0.25 0.23 0.26 0.63 0.22 0.1 -0.19 
Lens vault /μm -0.16 1.0 -0.58 -0.63 -0.53 -0.61 -0.66 -0.34 0.14 
AOD500/mm 0.25 -0.58 1.0 0.97 0.97 0.99 0.89 0.58 -0.38 
AOD750/mm 0.23 -0.63 0.97 1.0 0.94 0.97 0.89 0.58 -0.40 
TISA500 /mm 0.26 -0.53 0.97 0.94 1.0 0.99 0.86 0.59 -0.33 
TISA750 0.63 -0.61 0.99 0.97 0.99 1.0 0.96 0.65 -0.56 
Angle/° 0.22 -0.66 0.89 0.89 0.86 0.96 1.0 0.53 -0.31 
Spur-to-iris root distance/mm 0.1 -0.34 0.58 0.58 0.59 0.65 0.53 1.0 -0.11 
Iris curvature/mm -0.19 0.14 -0.38 -0.40 -0.33 -0.56 -0.31 -0.11 1.0 
Table 2.7 Correlation matrix to show correlation between accommodating anterior segment optical coherence tomography (AS-OCT) parameters. All 
values represent Pearson correlation coefficient, apart from correlations between TISA750 and other parameters for which Spearman’s rank 
correlation is shown. ACD, anterior chamber depth; AOD, angle-opening distance; TISA, trabecular-iris space area
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2.4 Discussion 
 
 
The results of the agreement study indicated that there was very good within- and 
between-observer agreement in classifying iris curvature as convex, flat or concave. 
Reassuringly there were no cases where an image was classified as showing a concave 
profile by one observer but convex by another; this is noteworthy because the iris 
curvature is not uniform throughout its length and a particular segment of the iris may 
appear convex whilst a different section appears flat or concave. Agreement with 
regard to quantification of iris curvature was deemed reasonable as 95% LoA between 
-0.06 and 0.04 mm represent a relatively narrow interval when considered in the 
context of the normal range of iris curvature measurements. The method described 
therefore appeared to be reliable in quantifying iris curvature from AS-OCT images. 
Establishing that there was satisfactory agreement using AS-OCT in the measurement 
of iris curvature was important prior to planning the case-control section of this study.  
The current study focused on agreement on iris curvature measurements on individual 
AS-OCT images. A limitation of the study was that variability of iris curvature over time 
for an individual patient was not addressed. Future work should ideally look at repeat 
AS-OCT images taken several hours and several days apart in order to determine to 
what extent iris curvature measurements may fluctuate over time. 
 
There is only one previously published study investigating between- and within-
observer agreement on measurements of iris curvature: Balidis et al. (89) used UBM to 
derive a metric known as the ‘R/D score’ to represent iris curvature; their method 
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relied on identifying the outermost point of iridolenticular contact, referred to as point 
A, constructing a line from this point to the peripheral end of the iris pigment 
epithelium and measuring the angle between this line and a line tangent to the lens 
also originating from point A, an angle known as the reference angle, R. The point of 
maximum iris displacement was then identified, either anteriorly or posteriorly, usually 
in the mid-peripheral iris and a 3rd line was then constructed through this point also 
originating from point A. The angle between this line and the line tangent to the lens 
was known as the displacement angle, D. The authors stated that in an eye with a flat 
iris configuration, the ratio R/D will equal 1 and that the greater the ratio, the greater 
the concavity of the iris. Although there was substantial agreement between two of the 
observers there was only moderate agreement with a 3rd observer. The authors 
concluded that assessments should preferably be made by the same observer when 
using this technique. One of the strengths of their method is that only the peripheral 
segment of the iris not in contact with lens is used for the assessment of curvature 
which produces a measurement of iris curvature less dependent on the relative 
position of the lens. Inspection of the AS-OCT images suggests that the central iris may, 
to some extent, be conforming to the anterior lens surface. It might be preferable to 
exclude the segment of iris in direct contact with the lens when measuring iris 
curvature, as is the case with Balidis’ method, to avoid the effect of relative lens 
position on iris curvature. It would not, however, be possible to apply this method to 
determine iris curvature on images from the present study as irido-lenticular contact is 
not well delineated on AS-OCT. Instead the method used was that described by Carassa 
 72 
et al. (81) which assesses curvature along the whole length of the iris from the 
periphery to the pupil edge. 
 
Accommodation was stimulated by de-focusing an internal fixation target and relied 
upon the participant reporting blurring of the target, an approach which differed from 
the method used by Liu et al. (41) who held a -3.0 D and -6.0 D lens in front of the eye 
to stimulate accommodation.  However, using the internal fixation target allowed the 
subject to accommodate maximally thereby increasing the study’s ability to detect 
accommodation-induced changes. 
 
The method used for assessing iris root to scleral spur distance along the antero-
posterior axis had the advantage of better reflecting the proximity of the posterior iris 
pigment epithelium to the lens zonules and may therefore be a more relevant metric 
to the pathophysiology of pigment dispersion. The method used in the present study 
differed to that used by Sokol et al. (85) which directly measured the distance between 
the 2 landmarks and is usually an oblique measurement.  
 
This is the first report of AS-OCT parameters in PDS/PG and age-, sex- and refraction-
matched controls. All parameters studied were significantly different between groups 
and the parameter that best distinguished between groups was iris curvature in non-
accommodating eyes. Campbell (38) was the first to propose that in PDS the 
posteriorly bowed iris led to frictional contact between packets of anterior zonular 
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fibres and the posterior pigment epithelium resulting in pigment dispersion. The 
concept of the ‘reverse pupillary block’ mechanism was introduced by Karickoff (39). 
who proposed that excessive irido-lenticular contact causes the iris to act like a flap 
valve permitting unidirectional flow of aqueous from the posterior to the anterior 
chamber, maintaining the posterior bowing.  
 
More recently, Dorairaj et al. (44) studied the response of the iris to accommodation in 
eyes with narrow angles, PDS and controls (age and refraction matched to the PDS 
group) over time. The drop in curvature (i.e. change from a more convex to a more 
concave configuration) immediately after accommodation was greatest in the PDS 
group. Average curvature reduced from 60 ± 79 μm (mean + standard error of the 
mean (SEM) prior to accommodation to −3 ± 83 μm immediately after, although this 
change was not statistically significant. Continued imaging of the iris over the following 
3 minutes revealed that the concavity was not maintained and in fact reverted to a 
more convex configuration than was present at baseline (146 ± 94 μm). The curvature 
value at this point was significantly different to both baseline iris curvature and 
curvature immediately after accommodation. Furthermore, the subsequent reversal in 
iris curvature was faster in the PDS group than in the other 2 groups from which the 
authors inferred that the chronic posterior bowing of the iris in PDS is not the result of 
slow recovery from accommodation. In the present study the area under the ROC 
curve for baseline iris curvature was significantly greater than for accommodating iris 
curvature. Baseline iris curvature may therefore play a greater part in frictional irido-
 74 
lenticular contact than accommodation-induced changes in curvature. Prospective 
studies investigating the natural history of PDS should carefully assess baseline 
curvature in order to explore correlation with subsequent severity of the clinical 
phenotype and the risk of developing PG. 
 
The present study found iris curvature best distinguished PDS/PG cases from controls. 
In contrast, the UBM-based study by Mora et al. reported irido-corneal angle in near 
vision to be the best performing parameter. AS-OCT imaging does not require contact 
or a supine subject position and it is possible the magnitude of concavity detected by 
UBM is reduced through prevention of blinking. A limitation of the study is that the 
observer was not blinded to whether the images were from cases or controls. If the 
study were to be repeated it would be important to blind the observer in order to 
eliminate this source of potential bias. 
 
Age was moderately associated with accommodative iris curvature in both cohorts. The 
slope in figure 2.8 can be seen to level off after the age of 50 years and this may reflect 
loss of accommodation seen in presbyopia  after this age. In retrospect, it would have 
been useful to record the amplitude of accommodation and plotted these data against 
age in order to compare the curve with that from figure 2.8. Accommodation is 
associated with anterior movement of the lens and pupillary constriction. The anterior 
lens movement was likely to account for some of the concavity detected in this study 
as the central iris is pushed anteriorly by the lens and conforms to its contour whilst 
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the peripheral iris remains fixed giving rise to a concave configuration overall. Anterior 
lens movement reduces with age and this may explain the reduction in concavity in 
older patients. A weaker association with age was also detected with non-
accommodative iris curvature. Increasing age is associated with pupillary miosis and it 
may be the case that a smaller pupil stretches the iris resulting in a flatter iris 
configuration. The reduction in concavity with age may mean that older patients with 
PDS/PG will be less likely to benefit from LPI, which aims to reverse iris concavity; this 
lack of benefit is compounded by the fact that the TM has had a longer time to become 
overloaded with pigment in older patients and there may be a greater degree of TM 
dysfunction. Gandolfi et al. (35) reported that in older, normotensive PDS patients, LPI 
was less effective at preventing a subsequent IOP rise.  However, Ritch argues for the 
existence of a ‘burn-out’ phase in older subjects (23) with PDS and this may mean there 
is less need for LPI in older patients. Whilst there appears to be a role for LPI in 
reducing/reversing iris concavity (81, 96), studies have not demonstrated that this 
necessarily translates into a reduction in the risk of PG (55, 56, 97). The data from this 
study suggest that excessive baseline iris concavity is a key feature in the 
pathophysiology of PDS. There is a need for further studies in PDS patients to clarify 
the role of LPI in reducing pigment dispersion and the subsequent risk of raised IOP 
and PG. 
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3.1 Introduction 
 
3.1.1  Iris concavity in PDS and non-PDS eyes 
 
The role of iris concavity in the pathogenesis of PDS has been discussed in section 
1.2.4. In brief, excessive irido-lenticular contact causes the iris to act like a flap valve, 
permitting unidirectional flow of aqueous from the posterior to the anterior chamber, 
potentiating a concave iris configuration (39). Iris concavity predisposes to frictional 
contact between packets of anterior zonular fibres and the posterior pigment 
epithelium resulted in pigment dispersion (38). The iris becomes more concave (or less 
convex) with accommodation but this may be a transient phenomenon, reverting back 
to the original configuration despite continued accommodative effort (44). 
Physiological iris concavity has also been observed in normal subjects in the resting 
state (81) and following exercise (98) but its prevalence during eye growth in normal 
subjects is not well known. The tendency to iris concavity is more pronounced in 
myopic eyes (98) but its relationship with other ocular biometric parameters has not 
been studied to date.   
 
3.1.2 Myopia in school age children 
 
The incidence of myopia is increasing and several large studies from the USA and the 
Far East have provided data in school age children. The Singapore Cohort study Of the 
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Risk factors for Myopia (SCORM) (99) found that 34% of 7-9 year olds were myopic at 
baseline, whilst a large US study reported that only 10% of a slightly older cohort 
(mean age 10 years) were myopic (100). There are relatively little contemporary data 
on the UK prevalence/incidence of myopia in young people. Williams et al. (101) 
reported a prevalence of spherical equivalent (SE) < -1.5 diopters of 1.5% in 7 year olds 
from auto-refraction data in a cohort of children in the Avon area, South West England; 
this figure increased to 3.6% when the same cohort was re-examined 3 years later.  
 
Axial length (AL) is an easily measurable quantitative trait considered to be a 
component of refractive error (102).  A study in Japanese 7-13 year old myopes 
demonstrated the ability of the IOLMaster (Carl Zeiss Meditec, Dublin, CA) to provide 
highly repeatable AL measurements in this age group (103).  
 
3.1.3 Corneal biomechanical parameters and axial length 
 
There is some evidence that corneal biomechanical properties may be related to axial 
biometry. Corneal hysteresis (CH) is a parameter considered to represent the 
dampening or viscoelastic properties of the cornea (104). Song et al. (105) studied 
1153 secondary school children in rural China and found CH to be lower in eyes with 
longer AL. However, a cross sectional study of 271 Singaporean children (106), 
reporting on CH and the ‘corneal resistance factor’ (CRF), did not show any association 
with refractive error or axial length.  
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3.1.4  Additional data collection 
 
The present study provided the opportunity to collect non-ocular data which had 
potential relevance to the development of myopia. 
 
Birth weight has been associated with refractive error (107) and AL (108). There is 
evidence that control of eye growth differs between men and women (109). By 
collecting data on digit ratio, a putative marker for pre-natal androgen exposure (110-
112), whether eye growth differs between boys with greater or lesser exposure to 
maternal levels of androgens was investigated. Bio-impedance analysis measures body 
composition, in particular the percentage of body fat. Height, weight, percentage body 
fat and waist circumference provide an indication of general metabolic status and may 
reflect long-term insulin levels. Epidemiological evidence implicates a role for chronic 
hyperinsulinaemia in juvenile-onset myopia (113). The above easily measured 
parameters were therefore investigated in this cohort. 
 
3.1.5 Aims 
 
Prior to the advent of AS-OCT, imaging of the anterior segment in paediatric patients 
had been difficult owing to the relative invasive nature of UBM and as a result there 
are no normative data on iris curvature in paediatric populations.  
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The primary aims of the study were: 
 
1. To estimate the prevalence of iris concavity in 10-12 year old UK school boys at 
baseline and during accommodation 
2. To explore relationships between iris curvature and axial length/refractive error 
and between corneal biomechanical parameters and anterior segment/axial 
biometric measurements 
3. To investigate changes in anterior segment/axial biometric and corneal 
biomechanical parameters over a 2-year period 
 
The secondary aim of the study was to explore the influence of the following non-
ocular parameters: birth weight, digit ratio, height, weight, waist circumference and 
bio-impedance on ocular biometric parameters. 
 
3.2 Methods 
 
3.2.1  Eligibility and recruitment 
 
All students in 2 consecutive year groups at City of London School, an independent 
boys’ school, were considered eligible for enrolment. The 10-12 year old age group was 
selected as participants were sufficiently mature to be fully co-operative with data 
collection. The study was approved by the Moorfields and Whittington Research Ethics 
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Committee and adhered to the tenets of the Declaration of Helsinki.  
Following logistic arrangements with the school and an introductory lecture to the 
students, information sheets and consent forms were sent to all of the students and 
their parents.  
 
One hundred and forty boys were invited to take part in the baseline study (December 
2009). One eye of each participant was pre-selected at random using a web-based 
research randomization tool (114) and this eye was designated as the study eye. 
Participants from the baseline study were invited to take part in a follow up study 2 
years later. The methodology was identical for the follow up study with the additional 
collection of non-ocular data. 
 
3.2.2  Examination and imaging 
 
3.2.2.1  Visual Acuity 
 
Distance visual acuity was measured in each eye at 4 metres with their current 
spectacles if available (LogMAR Acuity Charts; Keeler, Ltd., Windsor,UK). Pinhole visual 
acuity was also measured if the initial visual acuity was logMAR 0.2 (Snellen equivalent 
6/9.5) or worse. 
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3.2.2.2  Assessment of Ocular Refraction 
 
Non-cycloplegic ocular refraction was measured using an autorefractor (Nvision-K5001; 
Shin-Nippon Commerce Inc., Tokyo, Japan). Manual focimetry was performed where 
spectacles were worn. 
 
3.2.2.3  Ocular Biometry 
 
The AL of the study eye was measured using laser interferometry (IOLMaster, Carl Zeiss 
Meditec Ltd, Welwyn Garden City, UK). The subject was asked to focus on the internal 
fixation target and the reflection of the alignment light was centred within the cross 
hairs on screen. A minimum of 5 measurements were taken and checked for 
consistency, paying attention to any software notifications indicating measurements 
required evaluation. Only measurements within 0.1 mm of each other were included in 
calculating mean AL. Readings with a signal-to-noise ratio < 2.0 were excluded. 
 
3.2.2.4  Corneal biomechanical properties 
 
The Ocular Response Analyzer (ORA, Reichert Inc, Depew, New York, USA) measures 
the corneal response to indentation by a rapid air pulse and derives values for CH and 
CRF (104, 115). The ORA device also uses corneal biomechanical data to generate 
corneal-compensated IOP (ccIOP), a measure of IOP that is less affected by corneal 
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properties (116). The ORA device was used to obtain at least 3 good quality 
measurements as determined by visual inspection of the waveform looking for sharp, 
well-defined raw signal peaks. ORA software generates a waveform score reflecting 
measurement quality. Only measurements with a waveform score ≥ 4 were included in 
the analysis.  
 
3.2.2.5  Anterior Segment Optical Coherence Tomography 
 
Images of the anterior segment were obtained using the Visante AS-OCT (Carl-Zeiss-
Meditec, Dublin, California, USA). The device uses an internal fixation device with the 
apparent viewing distance set to infinity by the instrument optics when the subject’s 
refraction is entered. The operator can stimulate accommodation by adjusting the 
focus of the internal fixation target. AS-OCT imaging of the horizontal and nasal 
quadrant was performed at near and distance fixation under dim illumination as 
described in section 2.2.1. 
 
3.2.2.5.1 Image processing 
 
The AS-OCT images were analysed using the device’s Visante 3.0 software by one 
investigator (AS); both accommodative and non-accommodative images were 
analysed. The following parameters were measured as described in section 2.2.4.2: 
central corneal thickness (CCT), anterior chamber depth (ACD), lens vault (LV), angle 
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opening distances at 500 and 750 microns from scleral spur (AOD500 and AOD750) and 
trabecular-iris space area at 500 and 750 microns from the scleral spur (TISA500 and 
TISA750).  
 
Between-observer agreement of semi-automated anterior segment parameters was 
assessed by randomly selecting 20 subjects for assessment by an experienced 
investigator (Miss Sancy Low).  
 
3.2.2.6  Non-ocular data collection (follow up study only) 
 
Waist circumference was measured at the mid-point between the lower border of the 
rib cage and the iliac crest using a soft non-stretchable tape to the nearest 0.1 cm . 
Standing height was measured using a stadiometer also to the nearest 0.1 cm. Weight 
and percentage body fat (derived from bio-impedance) were determined using the 
Tanita BC543 Body Composition Analyser (Tanita Corp., Tokyo, Japan).  The subject was 
instructed to stand on the device after removing shoes and socks. Age and height were 
entered when prompted. Weight and percentage body fat were returned on a digital 
display. 
 
Hand scans were taken using an Epson Perfection 1650 scanner. Right hand digit ratio 
was measured using Image J version 1.45s to measure the lengths of the index and ring 
fingers from the middle of the basal crease to the tip of the finger in pixels. Digit ratio 
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was obtained by dividing the length of the right hand index finger by the length of the 
right hand ring finger.  
 
3.2.2.7  Statistical analysis 
 
To determine which variables were predictive of iris curvature, multiple regression 
analysis was performed using 6 variables (spur-to-spur distance, ACD, LV, mean scleral 
spur angle, SE, and AL). Linear regression analysis was used to investigate the 
relationship between AL/spur-to-spur distance and CH/CRF (dependent variable). 
Bland-Altman plots were constructed to assess between-observer agreement of AS-
OCT parameters; the difference between observers and the magnitude of the 
parameter being measured was assessed for trend by linear regression analysis. 95 % 
limits of agreement (LoA) were calculated as appropriate. The relationship between 
ocular and non-ocular parameters was explored. Paired student t-test was used to 
compare measurements between the 2 time-points. Analyses were performed using 
Prism version 6.0c for Mac OS X, GraphPad Software, La Jolla California USA, 
www.graphpad.com and MedCalc for Windows, version 12.2.1.0 (MedCalc Software, 
Mariakerke, Belgium). 
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3.3 Results 
 
3.3.1  Baseline study (December 2009) 
 
One hundred and forty boys were invited to take part of whom 103 (73.6%) returned 
registration forms indicating a willingness to participate and 96  (68.6%) attended on 
the day. Mean (SD) age was 11.51 (0.5) years. Data on racial ancestry was not formally 
collected, although the approximate proportions were as follows: 79% Caucasian, 8% 
Indian, 5% Chinese, 5% mixed and 2% Japanese. Seven participants exited the testing 
circuit early in error and did not attend the AS-OCT station. The Visante image in 
accommodation from one participant showed marked ghosting and was excluded from 
the analysis. Seventy-nine subjects had at least 1 set of adequate quality ORA 
measurements.  
 
Summary data for age, AL, SE, CH, CRF and IOPcc are shown in table 3.1. All parameters 
were distributed normally as determined by the Kolmogorov-Smirnov test except for 
SE. AS-OCT measurements at distance fixation and accommodation are shown in table 
3.2. Figure 3.1 shows an example of an increase in iris concavity seen on 
accommodation. 
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Parameter Mean SD 
Spherical equivalent (dioptres) -0.33 1.7 
Axial length (mm) 23.80 0.95 
Corneal hysteresis (mmHg) 11.8 1.7 
Corneal resistance factor (mmHg) 11.9 1.8 
Corneal-compensated IOP (mmHg) 15.5 4.3 
Table 3.1  Baseline ocular characteristics of 2009 schoolboy cohort  
 
 
 
 
 
 
 
 
 
Figure 3.1 Example AS-OCT image showing a slightly concave iris curvature on distance fixation 
(upper image) with a marked increase in iris concavity in the same eye on near fixation 
(lower picture) 
 
  
 89 
Parameter 
 
Non-accommodating  
(n=89) 
Accommodating  
(n=88) 
P* 
 Mean SD Mean SD  
Iris curvature (mm) -0.002 0.12 -0.21 0.18 <0.0001 
CCT (μm) 531.8 34.0 530.7 36.4 0.52 
ACD (mm) 3.34 0.27 3.11 0.31 <0.0001 
Lens vault (μm) -171.5 190.9 46.9 259.0 <0.0001 
Temporal AOD 500(μm) 851.0 312.1 933.0 331.6 0.0034 
Temporal TISA 500(mm
2
) 0.303 0.117 0.321 0.124 0.24 
Temporal scleral spur angle (˚) 56.9 10.4 59.5 9.3 0.0023 
Nasal AOD 500(μm) 806.6 295.4 895.7 334.3 0.0008 
Nasal TISA 500(mm
2
) 0.275 0.099 0.294 0.108 0.03 
Nasal scleral spur angle (˚) 56.3 9.8 58.8 9.9 0.0043 
Spur to spur distance (mm) 11.99 0.47 11.96 0.48 0.69 
Table 3.2  Summary for AS-OCT parameters in 2009 schoolboy cohort. *Paired t-test. CCT, central 
corneal thickness; ACD, anterior chamber depth; AOD, angle-opening distance; TISA, 
trabecular-iris space area 
 
 
The prevalence of iris concavity in the non-accommodative state was 24% and on 
accommodation this increased to 65%. Although not formally recorded, the 
accommodative amplitude as measured by the AS-OCT was approximately 10 D for this 
chort. Multiple regression analysis revealed the only variable significantly associated 
with non-accommodating iris curvature was lens vault (R2 = 0.23, P = 0.028). A 
scatterplot of lens vault against non-accommodating iris curvature is shown in figure 
3.2. Variables significantly associated with accommodating iris curvature were ACD (t = 
2.68, P = 0.009), lens vault (t = -2.01, P = 0.047) and scleral spur angle (t = -5.1, P < 
0.0001). For these 3 variables acting jointly, R2 = 0.33.  
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Figure 3.2  Scatterplot of lens vault against non-accommodating iris curvature in 2009 schoolboy 
cohort. Regression equation: y = 0.0003x + 0.04. 
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CH and CRF were both associated with spur-to-spur distance in the non-
accommodating state (R2 = 0.07 for both, P = 0.025 and 0.027 respectively). CH (but not 
CRF) was associated with spur-to-spur distance in accommodation (R2 = 0.11, P= 
0.005). No significant association was found between CH/CRF and AL. Spur-to-spur 
distance and axial length were significantly correlated (r = 0.29, P = 0.007). 
 
There were statistically significant differences between near and distance 
measurements for all angle metrics except temporal TISA500 (P = 0.09). Mean anterior 
lens surface movement on accommodation was 0.23 mm (SD 0.17mm).  
 
In the Bland Altman plots, the measurement difference between observers was 
unrelated to the magnitude of the measurement for all parameters. 95 % limits of 
agreement (LoA) together with the range of values in this cohort are shown in table 
3.3. The criterion for minimum acceptable LoA is a clinical decision, judged against the 
range of values of the parameter being measured (90). CCT, ACD and spur-to-spur 
distance demonstrated reasonably good agreement whereas LV, scleral spur angle and 
all AOD and TISA measurements demonstrated moderate agreement when considering 
the range of values for these parameters. Interestingly, ACD and spur-to-spur distance 
were both operator-determined but showed better agreement than the angle metrics 
that were software-determined.  
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Parameter Range Mean difference 95 % Limits of 
agreement 
CCT (μm) 440 to 650 -1.8 -18.3 to +14.8 
ACD (mm) 2.44 to 4.00 0.01 -0.08 to +0.09 
Lens vault (μm) -560 to 770 41.5 -93.3 to +176.3 
Temporal AOD 500 (μm) 0 to 2016 -120 -380 to +150 
Temporal AOD 750 (μm) 0 to 2245 -120 -390 to +160 
Temporal TISA 500 (mm
2
) 0 to 0.837 -0.04 -0.13 to +0.05 
Temporal TISA 750 (mm
2
) 0 to 1.357 -0.07 -0.21 to +0.08 
Temporal scleral spur angle (˚) 20.9 to 79.3 -3.9 -12.6 to +4.9 
Spur-to-spur distance (mm) 10.29 to 13.10 0.07 -0.1 to +0.24 
Nasal AOD 500 (μm) 0 to 1698 -80 -370 to +210 
Nasal AOD 750 (μm) 0 to 2170  -80 -420 to +250 
Nasal TISA 500 (mm
2
) 0 to 0.568 -0.02 -0.13 to +0.08 
Nasal TISA 750 (mm
2
) 0 to 1.063 -0.05 -0.22 to +0.13 
Nasal scleral spur angle (˚) 29.1 to 76.6 -2.7 -11.6 to +6.2 
Table 3.3 Between-observer agreement on AS-OCT parameters on 40 images (accommodative 
and non-accommodative scans) from 20 randomly selected subjects from 2009 
schoolboy cohort 
 
Fourteen participants had an uncorrected refractive error (defined as visual acuity of 
LogMAR 0.2 or worse which improved with pin-hole) and letters were written to the 
parents of these participants advising them of the need for an optometric assessment. 
One participant was subsequently diagnosed as having keratoconus. Ten participants 
had ORA IOPcc values of greater than 21 mmHg and were offered appointments in a 
Paediatric Ophthalmology clinic and of these, 1 participant was noted to have 
significant angle recession secondary to a prior ocular injury.  
 
3.3.2  Follow up study (December 2011) 
 
Out of 96 pupils invited to take part, 62 (64.6%) agreed and took part. Near and 
distance scans from 1 student and the near scan from another were excluded due to 
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poor image quality. Iris curvature measurements were not possible in an additional 3 
accommodative scans and 2 non-accommodative scans, due to difficulty identifying the 
posterior iris pigment epithelium. ORA measurements from 4 subjects were excluded, 
as waveform scores were consistently less than 4. Summary data are shown in table 
3.4. All parameters were normally distributed based on the Kolmogorov-Smirnov test, 
except for iris curvature in distance fixation, which showed a longer tail at lower values 
of iris curvature. There was no significant difference in refractive error between those 
who participated 2 years later and those who did not (mean SE -0.44 D and -0.37D 
respectively, P = 0.86). 
 
Table 3.4  Ocular and non-ocular characteristics of 2011 schoolboy cohort 
 
 
For the purposes of this study, iris concavity was defined as iris curvature <-0.1mm. 
The prevalence of iris concavity was 19/59 (32%) at distance fixation and 49/58 (84%) 
at near fixation. The distributions of non-accommodative and accommodative iris 
curvature are shown in figures 3.3 and 3.4 respectively.  
Parameter N Mean SD 
Axial length (mm) 62 24.01 1.04 
Spherical equivalent (dioptres) 62 -1.09 1.91 
Iris curvature A (mm) 57 -0.25 0.17 
Iris curvature NA (mm) 59 -0.02 0.14 
Spur-to-spur distance A (mm) 60 12.1 0.48 
Spur-to-spur distance NA (mm) 61 12.1 0.47 
Mean digit ratio 62 0.95 0.033 
Height (cm) 62 164.45 8.58 
Corneal hysteresis (mmHg) 59 11.4 1.64 
Corneal resistance factor (mmHg) 59 11.5 1.98 
Weight (kg) 62 53.7 11.38 
Waist circumference (cm) 62 72.3 7.93 
Percentage body fat 62 16.2 6.24 
Birth weight (kg) 61 3.34 0.78 
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Figure 3.3  Histogram to show distribution of non-accommodating iris curvature in 2009 and 2011 
 
 
 
Figure 3.4 Histogram to show distribution of accommodating iris curvature in 2009 and 2011 
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Variables significantly associated with non-accommodating iris curvature were ACD (t = 
2.25, P = 0.029) and mean scleral spur angle (t = -4,11, P = 0.0001). For both variables 
acting jointly, R2-adjusted= 0.59. Variables significantly associated with accommodating 
iris curvature were ACD (t = 2.34, P = 0.02), lens vault (t = -2.01, P = 0.047) and scleral 
spur angle (t = -7.30, P < 0.0001). For both variables acting jointly, R2-adjusted= 0.62. 
 
Significant association was found between CH and non-accommodating spur-to-spur 
distance (R2 = 0.07, P = 0.047) as well as CH and accommodating spur-to-spur distance 
(R2 = 0.13, P = 0.0067) (figure 3.5).  
 
 
Figure 3.5 Scatterplot of corneal hysteresis against spur-to-spur distance on accommodation for 
2011 schoolboy cohort. Regression line:  y = -0.11x + 13.3 
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There was a mean increase in AL of 0.22mm (paired t-test, P < 0.0001) and mean 
decrease in SE of 0.70 D compared to 2009 (paired t-test, P < 0.0001). Mean iris 
curvature at distance fixation reduced from -0.002 mm in 2009 to -0.02 in 2011 (P = 
0.40) and at near fixation reduced from -0.21 in 2009 to -0.25 in 2011 (P = 0.19). A 
comparison of parameters between baseline and follow up is shown in table 3.5. 
 
Parameter 2009 2011 Difference P 
Axial length (mm) 23.79 24.01 0.22 <0.0001 
Spherical equivalent (dioptres) -0.39 -1.09 -0.7 <0.0001 
Corneal hysteresis (mmHg) 11.6 11.4 -0.2 0.35 
Corneal resistance factor (mmHg) 11.7 11.5 -0.2 0.25 
Iris curvature NA (mm) -0.016 -0.019 -0.003 0.77 
Iris curvature A (mm) -0.198 -0.246 -0.048 0.11 
Anterior chamber depth NA (mm) 3.37 3.39 0.02 0.17 
Anterior chamber depth A (mm) 3.14 3.15 0.01 0.61 
Scleral spur angle NA (˚) 58.4 56.6 -1.8 0.02 
Scleral spur angle A (˚) 60.4 58.4 -2 0.11 
Lens vault NA (μm) -165.6 -179.2 -13.6 0.52 
Lens vault A (μm) 64.3 58 -6.3 0.8 
Spur-to-spur distance NA (mm) 12.06 12.13 0.07 0.13 
Spur-to-spur distance A (mm) 12.05 12.12 0.07 0.08 
Table 3.5  Comparison of ocular biometric parameters between 2009 and 2011 schoolboy 
cohorts. *Paired t-test. ACD= anterior chamber depth, AOD= angle-opening distance, 
TISA= trabecular-iris space area. Values shown for scleral spur angle represent 
temporal quadrant. Values for nasal angle were similar. 
 
 
Angle-opening distance (AOD), trabecular-iris space area (TISA), LV and scleral spur 
angle all show significant increases on accommodation (table 3.6), a finding that was 
also noted in the 2009 cohort.  
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 Non-accommodating 
(n=61) 
Accommodating 
(n=60) 
P* 
 Mean SD Mean SD  
Iris curvature (mm) -0.02 0.14 -0.25 0.17 <0.0001 
CCT (μm) 531.7 30.1 528.5 32.1 0.07 
ACD (mm) 3.38 0.28 3.14 0.31 <0.0001 
Lens vault (μm) -176.2 217.6 59.3 223.4 <0.0001 
Temporal AOD 500(μm) 822.4 318.4 907.8 379.0 0.0016 
Temporal AOD 750(μm) 1084.5 366.8 1185.5 398.7 0.0006 
Temporal TISA 500(mm
2
) 0.295 0.122 0.315 0.136 0.036 
Temporal TISA 750(mm
2
) 0.536 0.210 0.580 0.237 0.006 
Temporal scleral spur angle (˚) 55.8 10.5 57.6 11.5 0.03 
Nasal AOD 500(μm) 794.3 312.2 946.1 330.0 <0.0001 
Nasal AOD 750(μm) 1069.1 362.6 1233.3 392.1 <0.0001 
Nasal TISA 500(mm
2
) 0.277 0.112 0.312 0.115 0.0014 
Nasal TISA 750(mm
2
) 0.512 0.199 0.591 0.203 <0.0001 
Nasal scleral spur angle (˚) 55.5 11.0 60.4 9.4 <0.0001 
Spur to spur distance (mm) 12.17 0.48 12.10 0.48 0.78 
Table 3.6  Summary data for AS-OCT parameters in 2011 schoolboy cohort. *Paired t-test. CCT= 
central corneal thickness, ACD= anterior chamber depth, AOD= angle-opening distance, 
TISA= trabecular-iris space area 
 
No significant association was found between any ocular and non-ocular 
measurements. There was no statistically significant difference between CH/CRF values 
in 2009 and 2011.  No significant association was detected between baseline CH, 
baseline CRF or non-ocular measurements and change in AL, SE and spur-to-spur 
distance. 
 
3.4 Discussion 
 
Iris concavity in PDS leads to increased frictional contact between the posterior iris 
surface and the lens zonules, thereby predisposing to PG. Iris concavity in the absence 
of PDS has been described (81, 87) but its prevalence has not been reported. As PG is a 
condition that often affects young males, this study was designed to look at the 
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prevalence of iris concavity in a cohort of males before the age at which PDS is typically 
identified.  
 
Iris concavity was significantly more prevalent during accommodation than with 
distance fixation. The most widely accepted theory of accommodation is that put 
forward by Helmholtz (117) which states that contraction of the ciliary muscle relaxes 
the tension in the lens zonules which allows the lens to revert to a thicker and more 
convex form. Drexler et al. (43) studied changes in lens position in 10 healthy eyes in 
subjects whose mean age was 30 years and whose refractive error ranged from 
emmetropia to -5 dioptres using partial coherence interferometry. During 
accommodation the mean forward movement + standard deviation (SD) of the anterior 
pole of the lens was 185 + 89 µm whilst the backwards movement of the posterior pole 
was 69 + 39 µm. The mean forward movement of the anterior pole in the present study 
was 230 µm and it is likely the greater value in the present study reflects the larger 
accommodative amplitude (approximately 10 D) found in the school-age cohort. 
Sheppard et al. (118) demonstrated a decrease in anterior and posterior radius of 
curvature during accommodation in 15 young (19-29 years) emmetropes using 
magnetic resonance imaging as well as an increase in lens thickness and decrease in AC 
depth.  Visual inspection of the images from our cohort suggests that the central iris 
may be conforming to the curvature of the lens as it moves anteriorly (figure 3.1). The 
most important determinant of iris concavity in accommodation was a smaller ACD. 
This would also support the hypothesis of anterior lens movement causing increased 
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iris concavity.  However, if miosis and forward movement of the anterior lens pole are 
the only conformational change, this would cause a reduction in the anterior chamber 
angle, AOD and TISA on accommodation, rather than the increase observed (table 3.2). 
As there appeared to be accommodation-induced changes in the peripheral iris, it is 
unlikely that the changes seen in iris curvature could be explained solely by anterior 
lens movement acting on the central iris. Accommodation-induced change in lens 
position and miosis are likely to increase the area of contact between the iris and lens 
and this may result in a reverse pupillary block effect, similar to that seen in PDS, 
permitting mainly unidirectional flow from the posterior to the anterior chamber. The 
consequent increase in pressure in the anterior chamber relative to the posterior 
chamber may result in posterior displacement of the peripheral iris and this represents 
a possible explanation for the increase in angle parameters seen on accommodation. It 
should be mentioned that accommodation-induced miosis  may confound the 
assessment of iris configuration; future studies should address this by varying the 
ambient light intensity in order to achieve equal pupil sizes in the accommodative and 
non-accommodative states. 
 
24% of eyes exhibited iris concavity in the non-accommodative state. As the prevalence 
of PDS in a white population is reportedly 2.5% (34), the vast majority of these eyes are 
unlikely to develop PDS. It may be that iris concavity and the associated irido-lenticular 
contact must persist into adulthood for the development of PDS or other features need 
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to be present to induce pigment dispersion, such as factors intrinsic to the iris of PDS 
patients causing susceptibility to zonular abrasion or pigment shedding.  
 
Good between- and within-observer agreement of the iris concavity measurements 
used in this study has previously been shown in a cohort of adult PDS patients (119). 
Between-observer agreement was investigated for the semi-automated AS-OCT 
parameters. Liu et al.(120) reported that scleral spur identification was more difficult in 
eyes with narrow angles. In general, scleral spur visibility was good in the vast majority 
of images in the present study; this was supported by better agreement for scleral spur 
angle and spur-to-spur distance whereas agreement for the automated readings for 
AOD and TISA were less good. Agreement for AOD and TISA may have been poorer as 
calculation of these parameters is dependent on the software correctly detecting the  
iris and corneal endothelial surfaces.  
 
CH, CRF and IOP measured by the ORA have previously been described (104). Kirwan et 
al. (121) reported non-contact tonometry with the ORA to be an accurate method of 
determining IOP and found children cooperated better with this technique than with 
Goldmann applanation tonometry. Lower CH has been associated with longer AL in 
Chinese school children (105, 122) although Lim et al.(106) did not find any association 
with AL or refractive error in their study of 271 Singaporean (68.6% Chinese) children. 
Chang et al.(123) studied 126 eyes of 63 Taiwanese (predominantly Han Chinese) 
children and found that the difference in CH between the two eyes of each patient 
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correlated significantly with the difference in the AL between the two eyes. There was 
no relationship between ORA measurements and AL in the present study. The fact that 
CH and spur-to-spur distance were consistently associated at both time points in a 
relatively small sample is noteworthy and suggests that corneal biomechanical 
properties, as measured by the ORA, are associated with anterior segment geometry. 
No association was detected between CH/CRF and AL, although no AL and spur-to-spur 
distance were significantly correlated, raising the possibility that an underlying 
association between CH/CRF and AL may still exist despite not reaching statistical 
significance in the present study. No association was detected between baseline 
CH/CRF and changes in AL or spur-to-spur distance over the 2-year interval. Thus, the 
study did not find evidence that baseline corneal biomechanical parameters predict 
ocular growth, although the study was not powered to answer this question. 
 
The prevalence of iris concavity in this cohort was greater in 2011 (32% at distance 
fixation and 84% at near fixation) compared to 2009 (24% and 65% respectively), 
although there was no statistically significant difference in iris curvature measurements 
over the 2-year period for boys with data available from both visits. The higher 
prevalence might have reflected a selection bias, whereby myopes may have been 
more interested (either through parental encouragement or independently) in taking 
part in the second visit compared to non-myopes. However, analyzing the 2009 cohort 
revealed no significant difference in refractive error between those who participated 2 
years later and those who did not and so such selection bias appears unlikely. Figures 
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3.2 and 3.3 demonstrate a similar distribution of iris curvature in 2009 and 2011, 
supporting the view that selection bias was unlikely. Significant association was found 
between iris curvature and ACD in both accommodative and non-accommodative 
states, indicating that relative lens position may be an important determinant of iris 
curvature. However, there was no significant increase in ACD between 2009 and 2011 
suggesting that increased ACD did not account for the observed increase in concavity. 
A possible explanation is that an increase in iris size between iris root and pupil margin 
creates ‘redundant’ iris tissue which positions posteriorly in a concave configuration.  
 
The study presented an opportunity to collect additional data that were potentially 
relevant to ocular growth. Rahi et al. (107) found that myopia was positively associated 
with low birth weight for gestational age, whilst Saw et al. (108) reported that across 
the normal birth weight range, longer AL was associated with greater birth weight. 
However, Dirani et al.(124) analysed data from 1,224 twins from  the Genes in Myopia 
twin study and found no significant association between birth weight and myopia. 
 
The digit ratio is the ratio of the lengths of different digits or fingers typically measured 
from the bottom crease, where the finger joins the hand, to the tip of the finger. It has 
been suggested that the ratio of two digits (D) in particular, the 2nd (index finger; 2D) 
and 4th (ring finger; 4D), is affected by exposure to androgens e.g. testosterone while 
in the uterus and that this 2D:4D ratio can be considered a putative marker for 
prenatal androgen exposure, with lower 2D:4D ratios pointing to higher androgen 
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exposure (110-112). Interestingly, the differences are more pronounced in the right 
hand (125-127). There is evidence that control of eye growth differs between men and 
women (109) and by collecting data on digit ratio we aimed to explore whether eye 
growth differs between boys with greater or lesser exposure to maternal levels of 
androgens. Including a cohort of girls would have been of interest as this would have 
resulted in a greater range of values for exposure to maternal androgens but it was 
decided to use the limited resources to obtain a reasonable sized cohort of boys rather 
than a small cohort of boys and girls. 
 
Birth weight and digit ratio are both markers of intra-uterine experience and Barker’s 
theory (128) suggests that intrauterine experiences have a lifelong impact on health. 
Bio-impedance monitors have been developed that can distinguish between lean and 
fat tissue based on differences in their conductance and impedance characteristics; 
furthermore, they are simple to use, cost-effective, portable and non-invasive. 
Excellent correlation has been shown between bio-impedance and fat-free mass as 
measured by hydrodensitometry (129) and its use has been validated in children (130, 
131). Height, weight, percentage body fat and waist circumference provide an 
indication of general metabolic status and may reflect long-term insulin levels. 
Epidemiological evidence implicates a role for chronic hyperinsulinaemia, secondary to 
the refined sugars and starch in western diets, in juvenile-onset myopia because of its 
interaction with hormonal regulation of vitreal chamber growth (113). 
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No significant correlation was demonstrated between any of the above non-ocular 
parameters and AL, SE, CH, CRF (nor change in these parameters over the 2 years). The 
study was not powered to detect such associations, so this part of the study was 
considered exploratory, given the clinical importance of identifying risk factors for 
myopia. 
 
The school at which this study was conducted has a strong focus on academic 
achievement. Participants in the present study may not be representative of the wider 
cross-section of this age group and a limitation of the present study is that the findings 
may not be widely generalizable. Another limitation is the relatively small sample size. 
 
Iris concavity appears to be a frequent finding in this cohort at both time points. It is 
likely that the prevalence of iris concavity will fall as the cohort approaches adulthood 
on the basis that iris concavity in adults appears to be uncommon (81). Iris curvature 
was associated with LV, ACD scleral spur angle. It remains unclear whether there may 
be anatomical differences between the type of iris concavity found in our cohort and 
that found in PDS and this remains an area for further study. The data support the 
hypothesis that physiological iris concavity, which is more prominent during 
accommodation, may be related to a reverse pupil block mechanism. The anterior 
movement of the central iris alone did not explain the wider angle metrics and 
observed changes in iris curvature. The data also suggests there may be significant 
 105 
associations between corneal biomechanical parameters and ocular size (determined 
by spur-to-spur distance but not AL in this dataset).  
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4.1 Introduction 
 
Evidence for a genetic basis to PDS comes from the existence of families with multiple 
affected members (63,64). A genetic abnormality affecting the middle third of the eye 
during the third trimester has been proposed in order to explain the association with 
lattice degeneration, retinal tears and retinal detachment (23). Linkage analysis is a 
powerful tool for gene mapping in multigenerational families with clear Mendelian 
inheritance; this approach has been used in families with PDS demonstrating an 
autosomal dominant pattern of inheritance (63, 64). Data from screening first degree 
relatives of patients attending the PDS clinic at Moorfields Eye Hospital suggest that 
the majority of patients with PDS are not from autosomal dominant pedigrees and it 
may be that these cases represent either recessive inheritance or sporadic mutations. 
Identification of genes for PDS may provide information about molecular mechanisms 
underlying the pathogenesis and may uncover targets for novel therapeutic 
interventions. This chapter describes the results of linkage analysis in a pedigree 
segregating for PDS/PG showing an autosomal dominant mode of inheritance. 
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4.1.1  Concepts underlying linkage analysis 
 
4.1.1.1  Genetic markers and recombination fraction 
 
 Gene mapping in linkage studies is achieved by determining which genetic markers 
(whose chromosomal locations are already known) segregate with the disease of 
interest. The chromosomal region defined by these markers is likely to contain the 
disease susceptibility locus/gene. Recombination of homologous chromosomes occurs 
as a normal part of meiotic cell division. During prophase of meiosis I, pairs of 
homologous chromosomes exchange segments between individual chromatids, the 
point of crossover being known as a chiasma. If the gene of interest (location unknown) 
and a particular genetic marker (location known) are close together on a chromosome, 
the interval between these two loci is less likely to undergo recombination compared 
to a larger interval where the gene and marker are further apart. A central concept to 
linkage analysis is that of the ‘recombination fraction’ (denoted by ): for an individual 
heterozygous for 2 loci A and B, If alleles A1 and B1 are inherited from the mother and 
alleles A2 and B2 are inherited from the father, the individuals gametes may be 
recombinant i.e. A1 B2 or A2 B1 or non-recombinants i.e. A1 B1 or A2 B2. The 
recombination fraction is the proportion of gametes that are recombinant. 
Recombination is unlikely to separate 2 loci that are close together and the 
recombination fraction is therefore a measure of the distance between 2 loci. The 
recombination fraction ranges from =0 for loci immediately adjacent to one another 
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to 0.5 for widely separated loci (or loci on different chromosomes). Genetic distances 
are measured in centimorgans (cM) where 1cM is approximately equal to a 
recombination fraction of 1%. This relationship is less true over larger distances 
because of the existence of multiple crossovers (132). A mathematical relationship 
between recombination fraction and genetic map distance is given by a mapping 
function. A widely used mapping function is Kosambi’s function: 
w=1/4 ln [(1+2)/(1-2)] 
where w= map distance and  = recombination fraction 
Using Kosambi’s function, a recombination fraction of 0.27 translates into a genetic 
distance of 30cM (133).  
 
4.1.1.2  Haplotype blocks 
 
The majority of recombination occurs over short discrete regions of the chromosome 
known as recombination hotspots whilst the intervening regions form relatively stable 
‘haplotype blocks’ with low crossover rates.  Sets of alleles close together in a 
chromosomal region tend to be inherited together in these haplotype blocks and can 
be tracked through pedigrees providing a useful way of confirming that a particular 
chromosomal locus segregates with the disease (132). 
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4.1.1.3  Single nucleotide polymorphisms 
 
Single nucleotide polymorphisms (SNPs) are the most common type of genetic 
variation amongst individuals. An SNP represents a variation in a single nucleotide and 
occurs, on average, every 300 nucleotides. There are approximately 10 million SNPs 
spread over the human genome. They normally have only 2 alleles but due to their 
dense distribution across the genome and the ability of microarrays to assay over 
500,000 SNPs at a time they are presently the genetic marker of choice. 
 
4.1.1.4  Calculating the logarithm of the odds (LOD score) 
 
Once a pedigree has been collected and genotyped (i.e. their SNPs assayed), the first 
step in determining whether there is significant linkage to any SNPs is to work out the 
recombination fraction. For an affected individual whose children (considered to be his 
meiosis) need to be scored as recombinant or non-recombinant, this can only be done 
if a number of conditions are met: a) the individual is heterozygous at the marker in 
question, b) the individual’s parents’ affected status and genotype is known, and c) it 
can be determined which alleles were inherited from each of the individual’s parents. 
In a large number of cases, these conditions will not be met and computer software 
has been developed to deal with the inherent uncertainty in working out the 
recombination fraction. The probability that a marker is linked to the disease of 
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interest is given by the ratio of the overall likelihood given linkage: overall likelihood 
given no linkage. This is known as the likelihood ratio and is equal to: 
 
 (1-)m x n 
    0.5n+m  
 
where  is the recombination fraction, n is the number of recombinants and m the 
number of non-recombinants. The logarithm of this ratio is termed the LOD (logarithm 
of the odds) score, symbolised by Z. LOD scores are calculated over a range of  values 
with the most likely value of  being that with the highest LOD score (132).  
 
4.1.1.5  Threshold for significant linkage  
 
For a single test, the threshold for statistical significance is Z=3. As log101000=3, Z=3 
corresponds to a 1000:1 odds. Using Bayesian statistics with a 1 in 50 prior probability 
of linkage, 1000:1 odds corresponds to a joint probability (prior x conditional) of 1 in 20 
which equates to the conventional p = 0.05 test for statistical significance (134). In 
gene mapping studies, pedigrees are genotyped over thousands of markers, with a test 
for linkage being conducted at each marker. As this is an extreme case of multiple 
testing, it could be argued that a Bonferroni correction should be applied. However, 
this results in an overly stringent LOD score threshold as linkage data are not 
independent (if one location is excluded, the pre-test probability that another location 
is linked increases) (132). Empirical LOD score thresholds have been proposed: a LOD 
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score of 1 at the initial screening stage would be considered ‘interesting’, a LOD score 
of 2 would be considered ‘very interesting’ and LOD score of 3 would be indicative of 
‘provisional linkage’, awaiting confirmation from an independent dataset in order to be 
considered highly significant (135).  
 
4.1.2  Examples of glaucoma genes identified through linkage analysis 
 
Linkage analysis has been used to identify several loci in primary open angle glaucoma 
(POAG); myocilin and optineurin are both well-established glaucoma-causing genes 
identified through this approach.  
 
4.1.2.1  Myocilin 
 
A disease susceptibility locus for juvenile open-angle glaucoma, known as GLC1A, was 
originally mapped to 1q21-q31 by genetic linkage analysis of a 37-member pedigree 
segregating for JOAG in an autosomal dominant pattern (71). Mutation screening of 
candidate genes within this region identified 13 glaucoma patients with mutations in 
the TIGR (TM-induced glucocorticoid response protein) gene, subsequently renamed 
myocilin (MYOC) (70). 
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4.1.2.2  Optineurin 
 
Sarafarazi et al.(136) mapped a locus for normal tension glaucoma, GLC1E, to 10p15-
p14 through linkage analysis of a large British family demonstrating autosomal 
dominant inheritance. Subsequent work identified a missense mutation [Glu50  Lys 
(E50K)] in the optineurin (OPTN) gene located within this region. Sequence alterations 
in this gene were identified in 16.7% of 54 families with hereditary POAG (137). 
 
4.1.3  Linkage analysis in modern glaucoma gene mapping  
 
A novel POAG locus was more recently identified by Porter et al. (138). Linkage analysis 
was used to investigate a large 4-generation family with an autosomal dominant mode 
of inheritance. Ten affected members and 1 unaffected family member were 
genotyped and a significant LOD score of 3.1 centred at 4q35.1-q35.2 was found. 
Mutation analysis of 3 candidate genes LRP2BP, CYP4V2 and UFSP2 did not identify any 
mutations. 
4.1.4  Linkage analysis to map PDS susceptibility loci 
 
To date there have been 2 published loci, 7q31-36 and 18q21, identified through 
linkage analysis in autosomal dominant PDS pedigrees. The study presented here 
describes a linkage analysis on a British family with autosomal dominant PDS/PG with 
the aim of discovering novel PDS susceptibility loci. 
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4.2 Methods 
 
Ethical approval for the study was obtained from the Moorfields and Whittington 
Research Ethics Committee. The study was carried out according to the principles set 
out in the Declaration of Helsinki. Members of a 3-generation family with PDS/PG were 
enrolled into the study following informed consent. Family members were reviewed at 
Moorfields Eye Hospital (London, UK), Moorfields Eye Hospital Outreach Clinic at 
Northwick Park Hospital, Harrow (Greater London, UK) and Lincoln County Hospital 
(Lincolnshire, UK). 
 
4.2.1  Phenotyping 
 
A total of 15 family members were enrolled into the study. DNA from 2 members of 
generation II (subjects II:3 and II:4, figure 4.1) had previously been taken with informed 
consent although the clinical notes were no longer available. The proband stated that 
subject II:3 (proband’s father) had significant visual loss from glaucoma whilst subject 
II:4 (proband’s mother) had no known ophthalmic problems. All living members 
enrolled into the study were examined by a single ophthalmologist (AS). Where they 
existed, previous ophthalmic medical notes were reviewed. Participants were asked 
about their ophthalmic and medical history, including their medications and allergies. 
Detailed ophthalmic examination was performed on all subjects with particular 
emphasis on looking for the clinical signs of PDS/PG, including hyperpigmentation of 
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the drainage angle by performing gonioscopy with an Ocular Magna View Gonio Lens 
(Ocular Instruments Inc., Washington, USA). Applanation tonometry was performed 
with a Goldmann applanation tonometer using TonosafeTM disposable prisms. Dilated 
stereoscopic optic disc examination was performed in subjects with open angles. Visual 
fields were recorded using Humphrey 24-2 automated perimetry (Carl Zeiss Meditec, 
Dublin, CA). Glaucomatous optic neuropathy (GON) was defined as reproducible 
glaucomatous visual field (VF) defects with corresponding damage to the optic nerve 
head (cup disc ratio > or = 0.7 and/or focal narrowing of the neural rim) and the 
absence of retinal or neurological condition that may account for the VF loss. 
 
A glaucomatous VF was defined as a reproducible defect (in at least 2 consecutive 
reliable post-screening VFs) of two or more contiguous points with P < 0.01 loss or 
greater, or three or more contiguous points with P < 0.05 loss or greater, or a 10-dB 
difference across the nasal horizontal midline at two or more adjacent points in the 
total deviation plot (definition used in the UK Glaucoma Treatment Study (139)). 
 
4.2.2  Genotyping 
 
Participants’ DNA was extracted using the NucleonTM BACC2 DNA Extraction Kit (Tepnel 
Life Sciences, Manchester, UK) by Miss Beverley Scott, BMRC technician. DNA was 
prepared according to the protocol set out in Appendix 1. Prepared DNA was sent to 
the Wolfson Institute for Biomedical Research (WIBR) for hybridisation, 
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washing/staining and scanning. Genotyping was performed on an Affymetrix 50K 
Genechip. 
 
4.2.3  Analysis of genotypic data 
 
Genotype data from 15 individuals from this family were generated using the 50K Array 
Xba 240 Assay Kit from the GeneChip Human Mapping 100k Set (Affymetrix, High 
Wycombe, UK). Initial checks of the results were performed with GeneChip Command 
Console Viewer (v1.1.0.845). Genotyping Console (v3.0.2) was used to assign individual 
genotypes. Alohomora version 0.30 (Max Delbrück Center for Molecular Medicine, 
Berlin, Germany) was used to prepare the raw genotype data for total linkage analysis.  
PedCheck (version 1.1, Jeff O’Connell; University of Pittsburgh, Pittsburgh, PA, USA) 
was used to detect and remove Mendelian errors from the data. Genehunter (version 
2.1_r5 beta) was used to perform the subsequent parametric linkage analysis. The 
genetic model was specified as dominant and fully penetrant with a disease allele 
frequency of 0.0001. Merlin (80) was used to generate LOD scores. 
Regions showing promising LOD scores were refined using markers from Marshfield 
genetic maps (http://research.marshfieldclinic.org), the GDB Human genome database 
and Ensemble database (http://www.ensembl.org). Phenotype and genotype data 
were stored using Progeny software version 7.6.04 (Progeny Software, Florida, USA). 
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4.2.4  Candidate gene sequencing 
 
Candidate genes were selected from the regions identified by linkage analysis based on 
biological plausibility. Direct sequencing of the exonic regions of SERTAD4, TGFβ and 
ENTACTIN was performed in subjects III:9 (affected) and III:1 (unaffected). PCR primers 
were chosen to include the exonic sequence as well as a short section of adjacent 
intronic sequence. Amplicons were purified prior to sequencing using a purification kit 
(Qiagen Genclean Kit, Qiagen, Crawley, UK). Sequencing was performed using Big Dye 
3.1 terminator chemistry (Applied Biosystems, Warrington, UK) and run on an ABI 3730 
DNA sequencer (Applied Biosystems). Analysis of sequencing data was performed on 
Sequencher Version 4.1.4 (140). 
 
4.3  Results 
 
4.3.1  Clinical findings 
 
A clinical diagnosis of PDS or PG was made in 7 members of a 3-generation family of  
British ancestry with an autosomal dominant inheritance pattern (figure 4.1). There 
were no living members from generation I or II. Nine members from generation III and 
6 members from generation IV agreed to clinical phenotyping for the purposes of the 
study. Four members of generation III met the diagnostic criteria for pigment 
dispersion (III:2, III:5, III:7 and III:9). Three of these 4 subjects had GON (vertical cup to 
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disc ratio of 0.9 and previous trabeculectomy in at least one eye in 2 subjects and in 
the 3rd subject a vertical cup to disc ratio of 0.3 right eye and 0.6 left eye with previous 
trabeculectomy). The 4th pigment dispersion subject was classified as a glaucoma 
suspect on the basis of disc asymmetry (vertical cup to disc ratio 0.6 right eye, 0.4 left 
eye) in the absence of a significant visual field defect. Subjects 4 and 8 from generation 
III had glaucomatous optic neuropathy requiring trabeculectomy in at least one eye 
although clinical features at the time of examination were insufficient to meet 
diagnostic criteria for pigment dispersion. Subject III:1 had occludable angles without 
glaucomatous optic neuropathy and was referred to her local eye clinic with a 
recommendation for urgent YAG laser peripheral iridotomies. No subjects from 
generation IV met diagnostic criteria for pigment dispersion nor had definite 
glaucomatous optic neuropathy. Clinical characteristics of generations III and IV are 
presented in tables 4.1 and 4.2 respectively.
 120 
 
Figure 4.1  Autosomal dominant pigment dispersion pedigree. *Family members who attended for phenotyping. Individual deemed to have definite 
pigment dispersion syndrome.  Individual deemed to have definite glaucomatous optic neuropathy 
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4.3.1.1  Assignment of affected/unaffected status 
 
Whilst 4 subjects  (III:2, III:5 and III:7) had clear evidence of pigment dispersion, the 
existence of 2 additional subjects (III:4 and III:8) with clear GON without features of 
pigment dispersion raises uncertainties in determining their affectation status. Subjects 
III:4 and III:8 were aged 60 and 73 at the time that they were examined. There is 
evidence of a regression phase in some patients with pigment dispersion such that the 
clinical signs may fade with increasing age (23, 38) sometimes to the extent that 
patients may be misdiagnosed as having POAG or low-tension glaucoma (141). Whilst it 
was possible that pigment dispersion and POAG were segregating as 2 separate 
conditions in this pedigree, it was considered more likely that the 2 subjects in 
question had pigment dispersion giving rise to glaucomatous optic neuropathy but that 
the signs had faded by the time that they were examined: an age-related  
reversal of iris trans-illumination defects has been documented as has an age-related 
reduction in degree of TM pigmentation (33, 38). The assumption was therefore made 
in the analysis that these 2 subjects would both be classified as ‘affected’; this 
assumption extended to subject II:3 who had provided a blood sample for DNA analysis 
several years earlier to previous investigators but in whom no record of clinical 
examination could be found. The subject’s daughter stated that he had significant 
visual problems that she attributed to glaucoma. For the purposes of the analysis, 
therefore, he was also classified as ‘affected’. 
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Family 
member 
(age at 
presentation,
y) 
SE 
(D) 
 
AL 
(mm) 
Angle 
width 
(°) 
KS 
 
 RE         LE 
TID 
 
    RE       LE 
TMP 
 
RE       LE 
Max. IOP 
(mmHg) 
CCT 
(μm) 
MD (dB) CD ratio Comments 
III.1 (65)   5 RE 
5 LE 
0 0 0 0 0 0 18 BE   0.35 0.4 Occludable angles 
III.2 (71)   35 RE 
35 LE 
+ + + + ++ ++ 16 RE 
26 LE 
 -9.88RE 
-9.43LE 
0.9 0.7 Right trab 
III.3(62)  24.00 
RE 
23.97 
LE 
35 RE 
35 LE 
0 0 +/- +/- + + 20 BE  -1.1RE 
-1.71LE 
0.5 0.3 Right disc unchanged 
since 1999 
III.4(72) -0.88 RE 
-0.33 LE 
24.94 
LE 
 0 0 0 0 0 0 3 RE 
18LE 
 -30.29RE 
-25.52LE 
0.9 0.9 Bilateral trab, right RD, 
right chronic iritis 
III.5(80)   35 RE 
35 LE 
0 ++ 0 + ++ ++ 21 RE 
17 LE 
553 RE 
568 LE 
-4.04 RE 
-27.5 LE 
0.6 0.9 Left trab 
III.7(52) -2.38 RE 
-2.00 LE 
24.23 
RE 
24.37 
LE 
35 RE 
35 LE 
+ ++ 0 + + ++ 23 RE 
20 LE 
541 RE 
538 LE 
1.04 RE 
0.43 LE 
0.6 0.4 Right disc suspicious 
III.8 (61) -2.25 RE 24.91 
RE 
35 RE 
35 LE 
0 - 0 - + - 21 RE 490 RE - 0.9 - Left eye enucleation 
following cactus injury 
III.9 (56) -1.88 RE 
-3.13 LE 
25.70 
RE 
27.10 
LE 
40 RE 
40 LE 
+++ ++ ++ ++ +++ ++
+ 
32 RE 
27 LE 
542 RE 
539 LE 
-5.5 RE 
-5.2 LE 
0.3 0.6 Right trab 2003. Equal 
disc size. 
III.11 (67) 1.38 RE 
1.38 LE 
- 
- 
25 RE 
25 LE 
0 0 0 0 + ++ 16 RE 
18 LE 
 1.56 RE 
1.36 LE 
0.4 0.3 Disc height 1.3 RE, 1.1 LE 
Table 4.1 Clinical characteristics of generation III of PDS/PG family. SE = spherical equivalent, D = diopters, RE = right eye, LE = left eye,                                   
trab  = trabeculectomy,    RD = retinal detachment 
 123 
Family member 
(age at 
presentation,y) 
SE 
(D) 
 
AL (mm) Angle 
width 
(°) 
KS 
 
  RE         
LE 
TID 
 
 RE      
LE 
TMP 
 
RE         LE 
Max. 
IOP 
(mmHg
) 
CCT 
(μm) 
MD (dB) CD ratio 
 
RE        LE 
Comments 
IV.1(27)          19RE 
17LE 
560BE     
IV.3(25) -1.75 RE 
-1.75 LE 
24.91 RE 
24.94 LE 
35 RE 
35 LE 
+/
- 
+/- 0 0 + +  498 RE 
517 LE 
0.27 RE 
-0.1 LE 
   
IV.4(23) -0.375 RE 
-0.375 LE 
23.83 RE 
24.00 LE 
35 RE 
35 LE 
0 0 0 0 + + 14 BE 535 RE 
546 LE 
-2.39 RE 
-2.36 LE 
0.3 0.3 Left Adie’s pupil 
IV.5(24) -1.0 RE 
-0.375 LE 
23.02 RE 
23.03 LE 
- 
- 
0 0 0 0 - - - - - 0.3 0.3 Mild learning difficulties. 
Limited phenotyping 
possible 
IV.6(37) 0 RE 
0 LE 
- 
- 
35 RE 
35 LE 
0 0 0 0 +/- +/- 16 RE 
17LE 
581 RE 
580 LE 
- 0.3 0.3  
IV.7(27) 0 RE 
0 LE 
- 
- 
- 
- 
0 0 0 0 0 0 12 RE 
16 LE 
582 RE 
584 LE 
0.22 RE 
0.39 LE 
0.3 0.4 Disc height 1.3mm RE, 
1.1mm LE 
Table 4.2 Clinical characteristics of generation IV of PDS/PG family. SE = spherical equivalent, D = diopters, RE = right eye, LE = left eye 
4.3.2  Testing known PDS disease susceptibility loci 
 
Microsatellite markers were used to investigate 7q31-36 and 18q21 in III:9 (affected) 
and III:1 (unaffected) and both of these loci were excluded. 
 
4.3.3  Linkage analysis 
 
Haplotype analysis was performed by Dr N Waseem, Senior Post-doctoral fellow, 
Department of Genetics, UCL Institute of Ophthalmology. 
 
4.3.3.1  LOD scores and haplotype analysis 
 
Three chromosomal locations demonstrated promising LOD scores and were 
considered worthy of further investigation.  
1) A 20.0-Mb region with a maximum parametric LOD score of 2.12 was 
identified on chromosome 1q41-42.2 (figure 4.2). The maximum non-
parametric LOD score was 4.57. Haplotype analysis showed all affected 
family members sharing a common haplotype between D1S2703 and 
D1S2800 (figure 4.5). 
2) A 23.0-Mb region with a maximum parametric LOD score of 1.96 was 
identified on chromosome 10q25.1-q26.3 (figure 4.3). The maximum non-
parametric LOD score was 5.29. Haplotype analysis showed all affected 
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family members sharing a common haplotype between D10S597 and 
D10S1651 (figure 4.6). 
3) An 11-Mb region with a maximum parametric LOD score of 1.97 was 
identified on chromosome 22q13.1-q13.31 (figure 4.4). The maximum non-
parametric LOD score was 3.07. Haplotype analysis showed all affected 
family members sharing a common haplotype between D22S423 and 
D22S1149 (figure 4.7).  
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Figure 4.2  Parametric genome-wide LOD scores for chromosome 1. Physical chromosome position 
shown on x-axis and LOD score shown on y-axis 
 
 
Figure 4.3 Parametric genome-wide LOD scores for chromosome 10. Physical chromosome 
position shown on x-axis and LOD score shown on y-axis 
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Figure 4.4 Parametric genome-wide LOD scores for chromosome 22. Physical chromosome 
position shown on x-axis and LOD score shown on y-axis 
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Figure 4.5  Haplotype analysis for region of interest on chromosome 1 
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Figure 4.6  Haplotype analysis for region of interest on chromosome 10 
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Figure 4.7  Haplotype analysis for region of interest on chromosome 22 
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4.3.4  Sequencing candidate genes 
 
The following candidate genes from the region of interest on chromosome 1 were 
considered the best candidate genes based on biological plausibility: SERTAD 4, TGFβ2 
and ENTACTIN 1. SERTAD 4 is the human homologue of the murine Cdca4 expressed in 
the optic eminence of mouse embryos. TGF signalling has a role in the normal 
development of cornea, lens and retina in transgenic mice. ENTACTIN codes for a 
basement membrane protein, aberrations in which could render iris tissue more 
fragile. Sequencing of the coding regions in individuals III:9 (affected) and III:1 
(unaffected) revealed no missense or nonsense sequence changes that could have 
resulted in potentially pathogenic mutations. 
 
4.4 Discussion 
 
This chapter has described the phenotypic features of 2 generations of a family with 
what appeared to be an autosomal dominant form of PDS/PG. Linkage to known PDS 
loci were excluded and genome-wide linkage analysis was performed which 
demonstrated 3 chromosomal regions of interest each with parametric LOD scores 
close to 2.  
 
The family was identified after screening 297 PDS probands and their relatives in an 
effort to find families that might be suitable for linkage analysis. The family in the 
present study was the largest of those identified and was considered to be the most 
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suitable for linkage analysis. A number of assumptions were made in the analysis: it 
was assumed that individuals II:3 and II:4 (figure 4.1) were affected and unaffected 
respectively (based on the probands recollection of her parents’ ocular morbidity) and 
that GON seen in subjects III:4 and III:8 (figure 4.1) was secondary to pigment 
dispersion.  It was also assumed that the gene was fully penetrant. In fact, there may 
be other disease modifying genetic or environmental factors that affect whether the 
PDS phenotype is manifest. For example, as PDS has a predilection for myopic eyes it 
might be that emmetropic or hyperopic individuals with the PDS-causing genotype do 
not manifest the phenotype because their refractive state in some way is protective. 
Non-myopic eyes might not exhibit the iris concavity required for frictional contact 
with lens zonules thereby preventing pigment dispersion. Subject IV(4) was noted to 
have Adie’s pupil and may develop a miosed pupil in the long term; in theory, this may 
offer some protection against pigment dispersion as the miosed pupil is ‘on stretch’ 
and therefore less prone to iris concavity. 
 
No individuals in generation IV showed any of the 3 cardinal signs of PDS. As all were 
below 25 years of age, it was not possible to classify them confidently as unaffected 
and this generation was therefore excluded from the linkage analysis. Nevertheless, 
this family still represents a valuable resource for the identification of a disease 
susceptibility locus and it would be feasible to re-visit members of generation IV in 5 
years time when it is likely that some members of the generation may be exhibiting the 
clinical features. Entering genotypic data from affected members of generation IV may 
narrow the region of interest and/or increase the LOD score. 
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Of the 3 regions identified, the region on chromosome 1 was considered to show the 
strongest evidence for linkage.  As laboratory time and resources were limited, efforts 
to screen candidate genes were therefore focussed on this region. SERTAD 4, TGF2 
and ENTACTIN were considered the best candidate genes based on their known 
functions and expression patterns. 
 
SERTAD4 was identified as a result of work by Bennetts et al .(142) who isolated the 
murine Cdca4 gene  (cell division cycle associated 4) whilst conducting a genomic 
expression-based screen for genes involved in mammalian craniofacial development. 
Expression was demonstrated, amongst other regions, in sectioned mouse embryos in 
the optic eminence at day 13.5. The predicted CDCA4 protein contains a novel SERTA 
(SEI-1, RBT1 ((Replication Protein A Binding Trans-activator 1)and TARA (mammalian 
counterpart of Drosophila tara gene, a gene related to Cdca4) motif. High conservation 
between CDCA4 and previously characterised SERTA domain proteins, indicates a 
potential role for CDCA4 in cell cycle regulation and control of gene expression. 
Sequence homology searches identified a further evolutionarily conserved 
uncharacterised human member of the SERTA domain family; this sequence has been 
annotated as a predicted 356 amino acid peptide sequence and named SERTAD4.  
 
Ittner et al.(143) investigated the effect of neural crest cell specific inactivation of TGF 
signalling in transgenic mice; this was achieved by deletion of exon 4 of the TGF 
receptor type 2 (RT2), which leads to loss of TGFr2 protein expression in neural crest 
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stem cells. The cornea in TGF (RT2)-knockout embryos lacked an endothelial layer and 
the cornea and lens failed to separate whilst the retina showed diffuse patterning as 
opposed to clear structuring into anterior and posterior layers seen in controls. PDS 
eyes are likely to have some retinal involvement as the prevalence of lattice 
degeneration in these eyes has been reported to be 20-33% (27, 28). Normal formation 
of the TM and the ciliary body, indicated by a wrinkle in the iris primordium in control 
eyes, was not seen in TGFβr2-mutant eyes. The changes in the eyes of TGFβr2-mutant 
embryos were similar to those seen in human Axenfeld-Rieger’s anomaly, a condition 
characterised by posterior embryotoxon, iris stromal hypoplasia, corectopia, 
pseudopolycoria and ectropion uveae.  Iwao et al.(144) also described a similar 
transgenic mouse strain: heparan sulphate is required for TGFβ signalling which the 
authors were able to impair by disrupting the gene encoding exostosin 1, an enzyme 
required for heparan sulphate synthesis. The resulting phenotype displayed irido-
corneal angle dysgenesis and raised IOP. Finally, David et al.(145) reported a family 
with a balanced translocation t(1;7) (q41;p21) associated with Peter’s anomaly, a 
condition characterised by  iridocorneal adhesions or keratolenticular apposition; the 
authors reporting this family considered TGFβ2, located 500kb proximal to the 
breakpoint on chromosome 1, to be the main candidate gene.  
 
Entactin is an integral and ubiquitous component of the basement membrane and 
could serve as a bridge between laminin and type IV collagen. Evidence for this comes 
from work on human choriocarcinoma cells which synthesize laminin and type IV 
collagen but not entactin. Chung and Durkin (146) observed that transfection of 
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entactin into these cells stimulated incorporation of laminin and type IV collagen along 
with entactin into the extracellular matrix and into structures resembling focal 
contacts. ENTACTIN was considered a candidate gene on the basis that the absence of 
a basement membrane component might cause fragility of the posterior iris pigment 
epithelium making it prone to dispersing pigment. 
 
The regions identified though the linkage analysis were relatively broad, in the range of 
10-20-Mb, compared to a 1.9-Mb region identified by linkage analysis in a family with 
autosomal dominant POAG (138). The region of interest on chromosome 1, for 
example, contains hundreds of genes and it may not be justified to spend the 
considerable time and resources on screening the remaining genes within the region 
given the LOD score was considerably less than 3. Sanger sequencing, also known as 
the chain-termination method, was the standard method for gene sequencing used 
worldwide up until the end of the 20th century. The subsequent period has seen the 
development of next generation sequencing (NGS), a technology that is capable of 
massive parallel sequencing, during which millions of DNA segments are sequenced 
simultaneously with the result that an entire genome can be sequenced in less than 24 
hours. NGS involves fragmenting the DNA sample and attaching short adapter 
sequences onto the ends prior to amplifying. The fragments are then washed and 
nucleotides added in a pre-determined order. The addition of each nucleotide is 
recorded as the DNA segment is extended (147). Different platforms use different 
methods to record the sequence. The Illumina MiSeq platform works by detecting 
fluorescence emitted by pre-labelled nucleotides as the DNA fragment is extended 
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(148). Whilst linkage analysis has identified potential chromosomal regions of interest 
in this family, identification of the causative sequence change is difficult because the 
region identified is relatively wide. It is feasible to combine the linkage analysis 
described in this chapter with NGS technology in an effort to identify the responsible 
sequence variant. For example, Sobreira et al. (149) combined linkage information for 
metachondromatosis, a skeletal disorder affecting bone growth, leading to multiple 
enchondromas and osteochondromas with whole-genome DNA sequence in a single 
proband to identify a frameshift in PTPN11 that alters the reading frame and co-
segregates with the disease. Confirmation of this result was provided when a different 
mutation in the same gene was found to segregate with the disease in a different 
family.  
 
Another application of NGS technology is whole-exome sequencing. Whilst it is 
possible to sequence the entire genome on NGS platforms, disease causing mutations 
are much more likely to be found in the coding regions (exons) of the genome and it is 
therefore more efficient to focus resources on these regions, which comprise around 
1% of the total genome. Whole-exome sequencing may be useful in some of the 
smaller families that have been enrolled, with a view to identifying sequence variants 
that segregate with the disease; these smaller families would also be useful to validate 
any putative mutations that may be found in the family described in this chapter. 
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5.1 Introduction 
 
Patients with PDS/PG and their first-degree relatives were enrolled in an effort to find 
families suitable for linkage analysis (chapter 4). All participants had been carefully 
phenotyped and had provided blood samples for genetic studies into PDS/PG. Whilst 
most of these families were ultimately unsuitable for linkage analysis due to 
insufficient affected members, the project resulted in a DNA biobank for 130 PDS/PG 
probands. The DNA biobank was used in 2 ways: 1) a panel of 100 unrelated samples 
were used for a genome-wide association study (section 5.1.1), and, 2) a panel of 96 
unrelated samples was screened for mutations in GPNMB, the human homologue of 
the gene which causes a pigment dispersion phenotype in the DBA/2J mouse strain 
(section 5.1.2). 
 
5.1.1  Genome-wide association study 
 
5.1.1.1  Rationale  
 
Whilst linkage analysis has had some success in identifying chromosomal loci for PDS 
(63, 64), this approach has relied upon the assumption that PDS is a monogenic 
Mendelian condition, at least within the pedigrees that have been investigated. The 
following features of PDS, however, are more in keeping with a ‘complex’ (150) rather 
than a Mendelian genetic model: phenotypic heterogeneity, likely polygenic 
inheritance (as evidence by the existence of at least 2 genetic loci), phenocopies 
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(pigment dispersion as a result of surgery, trauma) and possible incomplete penetrance 
(subject III:3, table 4.1). Genetic factors in complex disease are likely to be relatively 
weak and/or heterogeneous compared to genes responsible for Mendelian disorders 
and, as such, linkage analysis is not as powerful a technique in the former compared to 
the latter. An alternative approach is to use association analysis, a method of 
investigating association across a population between a disease and a genetic marker.  
Weak effects are more readily detected by association rather than linkage (151).  
Lander put forward the hypothesis that common SNPs (minor allele frequency of at 
least 5%) are likely to account for at least some of the genetic contribution to common 
diseases (152). Genome-wide association studies (GWAS) typically type thousands or 
millions of SNPs across the whole genome across a cohort of cases and controls. 
Association analysis is conducted by determining the prevalence of each allele in cases 
and controls and then testing for statistically significant differences. 
 
5.1.1.2  Association analysis is based on linkage disequilibrium 
 
SNP variants that are situated close together on a chromosome tend to be inherited 
together, more so than would be predicted by their individual allele frequencies, in 
groups known as haplotype blocks; this non-random association of alleles is referred to 
as linkage disequilibrium (LD). Whilst GWAS can identify genetic regions that harbour 
risk-conferring SNPs, they will rarely identify the functional variant, which usually 
requires further genotyping of the region of interest as well as functional studies (153). 
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There have been two key developments which have made GWA studies feasible: 1) The 
International HapMap Project (http://hapmap.ncbi.nlm.nih.gov/) (154) typed several 
million SNPs in four human populations and provided detailed data on LD across the 
genome. Sets of 500,000 SNPs can act as ‘tags’ or proxys for approximately 80% of 
common SNPs (155). Interrogating these ‘tag’ SNPs on commercially available 
genotyping platforms allows efficient capture of variation across the whole genome.  
 
5.1.1.3  Examples of successful GWAS in ophthalmology 
 
5.1.1.3.1 Complement factor H in age-related macula degeneration 
 
The first successful application of the GWAS approach in ophthalmology was the 
discovery of the role of complement factor H gene in age-related macula degeneration 
(AMD) (156); this study reported results of a genome-wide scan of 96 cases and 50 
controls and identified association with the Y402H polymorphism at rs1061170 where 
a tyrosine is substituted by a histidine. The Y402H change has been replicated in other 
independent studies and has been associated with both early and late AMD, as well as 
dry (geographic atrophy) and wet (choroidal neovascular membrane) forms of the 
disease (reviewed in (157)). 
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5.1.1.3.2 E2-2 protein in Fuchs’s corneal dystrophy 
 
Baratz et al. (158) conducted a GWA study investigating Fuchs’ endothelial dystrophy 
(FED), a condition in which patients develop visual loss as a result of bilateral corneal 
endothelial failure. The GWA study included 130 FED subjects in the discovery cohort 
and an additional 150 subjects in a replication cohort; the strongest association was 
found at rs613872 in intron 3 of the transcription factor 4 (TCF4) gene (P = 1.01 x 10-12 
in the discovery cohort and 1.79 x 10-13 in the replication cohort), located on 
chromosome 18. TCF4 codes for the E2-2 protein, a member of a family of transcription 
factors involved in cellular growth and differentiation. 
 
5.1.1.4  Examples of successful GWAS in glaucoma 
 
5.1.1.4.1 LOXL1 in pseudoexfoliative glaucoma 
 
This study enrolled 195 glaucoma patients and 14474 controls and identified 2 coding 
variants at the LOXL1 loci rs1048661 and rs3825942 (159). Sub-group analysis 
determined that the signal was driven entirely by 75 patients with pseudoexfoliative 
glaucoma. These associations have subsequently been replicated in multiple studies 
across different populations (160). The G allele of rs3825942 has been consistently 
reported as the risk allele in multiple populations, however, a study of the LOXL1 
coding region in XFG subjects from South Africa found a strong association with the 
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opposite (A) allele (161). Williams et al. concluded that other, as yet unknown, causal 
variants of LOXL1 contribute to the genetic risk of XFG. 
 
No significant differences have been found in the risk of LOXL1 polymorphisms of 
developing PEX syndrome versus PEX glaucoma, which would implicate separate 
genetic or environmental factors in determining risk of raised IOP/GON (160). The 
present study has made a similar assumption regarding the genetic risk of raised 
IOP/PG in PDS and as such has classified all PDS subjects as ‘cases’ regardless of the 
presence or absence of PG.  
 
5.1.1.4.2 CAV1 and 2, TMCO1 and CDKN2B-AS1 in POAG  
 
The caveolin locus for POAG was discovered through a GWAS of 1,263 cases and 
34,877 controls from Iceland (162). A common sequence variant was identified at 7q31 
(rs4236601[A], odds ratio (OR) = 1.36, P = 5.0 × 10−10). The association with the 
caveolin locus was replicated in independent samples from Sweden, UK, Australia, 
Hong Kong and China and also in a further independent American cohort (163). The 
associated SNPs reside in a haplotype block which harbour the CAV1 and CAV2 genes 
which encode proteins involved in caveolae, small invaginations of the cell membrane 
involved in cell signalling and endocytosis. 
 
An Australian GWAS enrolling 615 subjects with advanced POAG and 3946 controls 
reported significant and replicated association at 2 loci: rs4656461 at 1q24 (OR = 1.68, 
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P = 6.1 x 10-10) and rs4977756 at 9p21 (OR = 1.50, P = 4.7 x 10-9); these loci implicate 
the TMCO1 gene and a long non-coding RNA called CDKN2B-AS1 respectively (164). 
 
5.1.1.5  Study design considerations 
 
Subjects for both the case and control group should ideally be from the same ancestry 
because SNP frequencies will vary across populations (165). Robust quality control of 
the genotypic data is required to detect problems with the SNP assay or DNA quality as 
well as to detect previously unknown relatedness amongst subjects and differences in 
ancestry between cases and controls. An appropriately matched control population 
must be selected. In the case of PDS, the control group should be matched for myopia, 
in order to avoid erroneously identifying SNPs for myopia rather than PDS. 
 
Correction must be made for multiple testing. GWAS typically test for association 
across at least 500,000 SNPs. Using a P-value of 0.05 in this context would result in 
25,000 SNPs being erroneously taken forward for replication studies as a result of false-
positive association. A more appropriate P-value can be obtained by dividing the 
threshold P-value by the number of tests (Bonferroni correction) although this value is 
overly stringent when the number of tests is large (132). 
 
Finally, any associations detected in the ‘discovery cohort’ would require replication in 
an independent cohort. 
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5.1.2  Screening for GPNMB sequence variants 
 
The DBA/2J mouse strain represents a mouse model for PG. The phenotype is 
attributed to mutations in Gpnmb and Tyrp1, which have been shown to cause iris 
pigment dispersion (IPD) and iris stromal atrophy (ISA) respectively (66, 166).  
 
The features of IPD are similar to PDS in man and comprise deterioration of the 
posterior iris pigment epithelium, slit-like iris transillumination defects and pronounced 
pigment dispersion. IPD is caused by a premature stop codon mutation in Gpnmb 
(R150X) (67). Transcription of Gpnmb is regulated by microphthalmia transcription 
factor (MITF). A MITF-binding site has been identified in the in the Gpnmb promoter 
and is conserved in different mammalian species (167). Bachner et al. (168) 
investigated Gpnmb mRNA in murine embryonic development. High levels were 
initially detected in the outer retina whereas in subsequent stages in development 
mRNA expression is restricted to the retinal pigment epithelium and iris. Bachner et 
al.concluded that Gpnmb was important in melanin biosynthesis and in retinal pigment 
epithelium and iris development; this is significant because human PDS involves retinal 
(28) as well as iris pathology. 
 
ISA is associated with a loss of iris stromal complexity and build up of iris stromal 
pigment and cellular debris in the drainage angle. ISA is caused by the recessive Tyrp1b 
mutant allele encoding a mutant protein containing two amino-acid substitutions. Mice 
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homozygous for mutations causing IPD and ISA have a more severe phenotype with an 
earlier age of onset and more aggressive GON than either mutation on its own (166).  
 
The relationship between levels of ocular pigmentation and the development of the 
ISA and IPD phenotypes is demonstrated in DBA/2J-pe mice, a strain bearing the pearl 
(pe) mutation in which the homozygous genotype causes hypopigmentation of coats 
and eyes. Despite homozygosity for GpnmbR150X and Tyrp1b, DBA/2J-pe mice 
homozygous for the pe mutations did not show the IPD or ISA phenotypes and also 
prevented the development of GON (67). Thus IPD and ISA phenotypes appear to be 
dependent upon the level of pigment production occurring in the adult eye.  
 
Mutations in human TYRP1 mutations cause OCA3 (169), a form of oculocutaneous 
albinism, with no reported increased risk of PG. Tyrosinase is an enzyme that catalyses 
the initial step in pigment production and TYRP1 forms part of a complex required for 
stabilsation of this enzyme. Mutant TYRP1 may fail to stabilize tyrosinase resulting in 
reduced pigment production and OCA3 may therefore be ‘self-rescuing’ with regard to 
the development of PG. Lynch et al. (170) sequenced the TYRP1 gene in probands from 
families segregating for PDS/PG. Lynch et al. identified 3 novel synonymous SNPs in 2 
PDS/PG subjects but report that these SNPs did not define a haplotype that segregated 
with the disease. No variants causing changes in the amino acid sequence were 
identified. 
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GPNMB codes for a highly glycosylated type I transmembrane protein and shows 
significant structural homology to the melanosomal structural protein, Pmel17 (171). 
The gene was first cloned when it was noted to show preferential expression levels in 
low-metastatic melanoma cell lines (172). Anderson et al. (67) sequenced the GPNMB 
coding region from 8 affected individuals in 4 families with autosomal dominant PDS 
and detected no mutations.  
 
As laboratory time was limited it was decided to sequence GPNMB in the panel of 
PDS/PG patients in preference to TYRP1. The IPD phenotype in DBA/2J mouse strain 
more closely resembled human pigment dispersion than the ISA phenotype and 
Gpnmb mRNA expression had been demonstrated in the retinal pigment epithelium as 
well as the iris of embryonic mice. For these reasons GPNMB was considered the better 
candidate gene for human pigment dispersion. 
 
5.2  Methods 
 
5.2.1  Genome-wide association study 
 
5.2.1.1  Case and control cohorts 
 
Patients with PDS or PG had been recruited from Moorfields Eye Hospital from 
December 2008 and July 2011. Patients were invited to attend for phenotyping and to 
provide a blood sample for DNA extraction. All participants had been phenotyped by 
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one investigator (AS) and had consented for their blood samples to be used for the 
purposes of genetic investigation into PDS. Diagnostic criteria for PDS have been stated 
in section 2.1. One hundred unrelated probands were selected to form the ‘case’ 
cohort. Patients with clear non-Caucasian ancestry were excluded from selection. The 
study was approved by the South East London Research Ethics Committee.  
 
The UK Twins Registry have a large cohort of patients with ophthalmic phenotypic data 
including refractive error, half of whom had been genotyped on the Illumina 317k 
platform, and half on the Illumina 610 Quad chip (550k plus 60k CNV SNPs). Agreement 
was obtained from the UK Twins Registry for access to genotypic data from a myopic 
cohort to serve as the control dataset.  
 
5.2.1.2  Sample size 
 
The OR of AMD prevalence in first-degree relatives of AMD probands has been 
estimated at 2.4-19.8 (173, 174); these estimates represent age- and sex- adjusted OR 
determined by comparing the prevalence of AMD in first-degree relatives of AMD 
probands with first-degree relatives of normal controls. There are no published data on 
the prevalence of PDS in first-degree relatives of probands. During efforts to identify 
PDS families suitable for linkage analysis, the prevalence of PDS in first-degree relatives 
of PDS probands was found to be approximately 20%. Although no similar study was 
conducted in relatives of control subjects, a crude estimate for this value is that of the 
published prevalence of 2.5% found during a screening study of New York office 
 150 
workers (34). Using these values, the corresponding OR of PDS prevalence in first 
degree relatives can be estimated to be 20/2.5=8. This approximation falls in the 
middle of the range for the OR for AMD quoted above, suggesting that a similar 
proposed sample size may be sufficient. Because the clinical signs of PDS fade with age, 
there is a risk that parents of probands may have been misclassified as unaffected 
whereas had they been examined in their 30s or 40s, may have been found to be 
affected. The prevalence figure of PDS in first-degree relatives might therefore be an 
underestimate and if this were the case, the OR would be even higher.  
 
5.2.1.3  DNA extraction and genotyping 
 
DNA was extraction from frozen samples was performed by Miss Beverley Scott, BMRC 
Technician, Department of Genetics, UCL Institute of Ophthalmology. Extracted DNA 
was assessed for protein contamination using a spectrophotometer (Nanodrop ND-
1000; Thermo Fisher Scientific Inc., Wilmington, USA). Samples with 260/230 values < 
1.8 were deemed to be contaminated and underwent ethanol precipitation. All 
samples were electrophoresed on a 1% agarose gel to ensure they were within the 10-
15 kbp range. Samples were frozen and shipped to a commercial service (Aros Applied 
Biotechnology, Denmark) for genotyping on the Illumina 660w Quad beadchip. 
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5.2.1.4  Quality control 
 
Quality control (QC) was performed by Miss Cristina Venturini and Dr Pirro Hysi, King’s 
College London, using Plink (175, 176) and ‘R’ (177). Genotype calling was performed 
on Illumina GenomeStudio software version 2011.1 (Illumina, San Diego, USA). QC was 
conducted according to a protocol published by Anderson et al. (178). 
 
5.2.2  Screening for GPNMB sequence variants 
 
Ninety-six unrelated patients were selected from the PDS probands who were 
originally enrolled when families suitable for linkage analysis were being sought.  DNA 
was extracted from peripheral blood lymphocytes. All 11 exons of GPNMB (including 
the promotor region) were amplified and sequenced on a 3730 DNA Analyser. Results 
were analysed using Sequence Analysis 5.2 and Sequencher 4.1.4. Potentially 
significant changes were screened for in a panel of normal DNAs. Variants resulting in 
amino acid changes were submitted to the following 3 web-based applications to 
estimate their functional significance: SIFT (179), PolyPhen-2 (180)  and PMut (181, 
182). 
  
 152 
5.3 Results 
 
5.3.1  Genome-wide association study 
 
5.3.1.1  Genotyping 
 
A pilot batch of 8 samples was initially genotyped to check call rates (table 5.1). 
 
0.9621 
0.9931 
0.9959 
0.9962 
0.9971 
0.9973 
0.9974 
0.9977 
 
Table 5.1 Illumina 660w Quad beadchip genotyping call rates for 8 ‘pilot’ samples from PDS 
cohort 
 
On the basis of the above result the remaining 92 samples were genotyped (table 5.2).  
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0.995
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0.995
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0.996
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0.997
6 
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0.900
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0.995
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0.995
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0.996
6 
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0.995
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0.996
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0.997
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0.995
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0.996
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0.997 0.997
3 
0.997
7 
0.998
8 0.747
2 
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2 
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8 
0.994
6 
0.995
3 
0.996 0.996
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0.996
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1 
0.997
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0.997
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0.763 0.933
8 
0.977
4 
0.994
7 
0.995
4 
0.996 0.996
4 
0.996
8 
0.997
1 
0.997
3 
0.997
8 0.767
1 
0.948
7 
0.980
4 
0.994
9 
0.995
5 
0.996
1 
0.996
5 
0.996
8 
0.997
2 
0.997
4 
0.998 
0.808
1 
0.951
1 
0.986
9 
0.995
2 
0.995
6 
0.996
1 
0.996
5 
0.996
8 
0.997
2 
0.997
4 
0.998 
 
Table 5.2 Illumina 660w Quad beadchip genotyping call rates for remaining samples from PDS 
cohort 
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5.3.1.2  Quality control 
 
5.3.1.2.1 Per-individual and per-marker missing genotypes 
 
The proportion of missing individuals and SNPs with missing genotypes is shown in 
figures 5.1 and 5.2 respectively. 
 
 
 
 
 
 
 
Figure 5.1  
 
Proportion (shown on the x-axis) of 
individuals with missing genotypes  
Figure 5.2 
 
Proportion of SNPs (shown on the 
x-axis) with missing genotypes 
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5.3.1.2.2 Sex check 
 
Homozygosity rates across all X-chromosome SNPs are shown figure 5.3. The data 
show 2 clusters: one around zero for females and another around 1 for males.  
 
 
Figure 5.3  X-chromosome homozygosity (on the x-axis) for PDS cohort. Red arrows indicate 
clusters away from expected values. 
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5.3.1.2.3  Racial /ethnic ancestry 
 
Reference population data from HapMap III (183) was used to find racial outliers. 
Figures 5.4 and 5.5 show the location of the PDS subjects in comparison with HapMap 
III populations. 
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Figure 5.4a 
 
 
Figure 5.4b 
 
Figure 5.4 Clustering of PDS subjects (blue circles) in comparison with HapMap III populations. The 
majority of the PDS samples can be seen to cluster with individuals of known Northern 
and Western European ancestry, confirming that the PDS cohort is mostly genetically 
homogeneous. One individual can be seen to cluster with indivuduals of Mexican and 
Gujurati Indian ancestry and would need to be exlcuded from the genome-wide analysis. 
The 3-dimensional data is represented by two 2-dimensional graphs. ASW African 
ancestry in Southwest USA; CEU Utah residents with Northern and Western European 
ancestry from the Centre d'Etude du Polymorphisme Humain collection; CHB Han 
Chinese in Beijing, China; CHD Chinese in Metropolitan Denver, Colorado; GIH Gujarati 
Indians in Houston, Texas; JPT Japanese in Tokyo, Japan; LWK Luhya in Webuye, Kenya; 
MXL Mexican ancestry in Los Angeles, California; MKK Maasai in Kinyawa, Kenya; TSI 
Toscani in Italia; YRI Yoruba in Ibadan, Nigeria 
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5.3.1.2.4  Principal component analysis 
 
Figures 5.5 and 5.6 show plots of principal components 1, 2 and 3. Plots for principal 
components 4 were similar (data not shown). 
 
          
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 5.5 
Plot of principal components 1 and 2 for 
genotypic data from PDS cohort. Outliers 
marked in red. 
 
Figure 5.6 
Plot of principal components 1 and 3 for 
genotypic data from PDS cohort. Outliers 
marked in red. 
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5.3.1.2.5 Hardy-Weinberg Equilibrium  
 
 A p-value for departure from Hardy-Weinberg Equilibrium (HWE) for each SNP was 
computed. The quantile-quantile plot is shown in figure 5.7. There is a departure from 
HWE after an expected chi-squared of approximately 7. 
 
 
Figure 5.7  Quantile-quantile plot showing the observed HWE Log p-values compared to the Log p-
values expected from a theoretical uniform distribution of the HWE probabilities 
 
  
 159 
5.3.1.2.6 Heterozygosity 
 
Individual heterozygosity was determined by calculating the ratio between the 
observed and expected number of heterozygotes. These data are illustrated in figure 
5.8.  
 
 
 
 
Figure 5.8  Plot of observed to expected heterozygosity ratio (red arrow indicates the small peak 
at a ratio of 0.75) 
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5.3.1.2.7 Relatedness 
 
Figure 5.9 depicts the frequency of different values of PI_HAT, a measured of 
estimated relatedness between any two samples. There is an apparent excess of 
sample pairs sharing approximately 20% of their DNA and also a smaller portion of 
sample pairs sharing between 60 and 85% of their DNA. 
 
  
 
 
 
 
 
Figure 5.9 Estimated relatedness (PI-HAT) between any 2 samples in the PDS cohort 
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5.3.2  Screening for GPNMB sequence variants 
 
One patient was found to have a missense change in exon 6 of GPNMB (figure 5.10). 
This protein change, proline to leucine at codon 325, was not present in 182 Caucasian 
control samples and deemed to be ‘tolerated’, ‘possibly damaging’ and ‘pathological’ 
according to SIFT, PolyPhen-2 and pMut respectively. Two patients were found to have 
a c.-179insT in exon 1 proximal to the TATA-like element regulatory region (figure 
5.11). The c.-179insT change was present in 1 out of 183 Caucasian control samples. 
 
 
Figure 5.10  Missesense change in exon 6 of GPNMB. Upper electropherogram shows region of 
exon 6 in patient with normal sequence. Lower electropherogram from patient 
showing c.C325T missense change in the same region 
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Figure 5.11  Nucleotide insertion in exon 1 of GPNMB. Upper chromatogram showing region from 
exon 1 in a patient with normal sequence. Middle and lower chromatograms revealing 
insertion upstream of the TATA-like regulatory region seen in 2 patients. Sequence 
annotations adapted from Ripoll et al. (167). 
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The patient demonstrating the c.C325T change was a 26 year old white male with a 
maximum IOP of 32 mmHg right eye and 28 mmHg left eye with no evidence of GON.  
 
Two patients demonstrated the c.-179insT change. The first was a 46 year old Somalian 
male with maximum IOP of 32 mmHg right eye and 35 mmHg left eye and evidence of 
bilateral GON. The second was a 55 year old white female with maximum IOP of 22 
mmHg right eye and 23 mmHg left eye with no evidence of GON. All 3 patients were 
phenotypically similar to the rest of the cohort. 
  
5.4  Discussion 
 
5.4.1  Genome-wide association study 
 
5.4.1.1  Quality control 
 
5.4.1.1.1 Per-individual and per-marker missing genotypes 
 
Genotypes are determined from probe intensity data by a genotype-calling algorithm 
within Illumina’s proprietary software. The proportion of missing data was investigated 
for both individuals and SNPs. The QC protocol (178) recommends conducting QC on a 
‘per-individual’ basis before doing so on a ‘per-marker’ basis to maximize the number 
of markers remaining in the study; this approach prevents markers from being 
erroneously removed because of a subset of poorly genotyped individuals, but 
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individuals may be falsely removed on the basis of a poorly genotyped subset of 
markers. When testing 550,000 markers, a 1% failure rate equates to 5,500 markers 
with the associated risk that a disease-associated SNP could be overlooked. For this 
reason, in a study with a large number of subjects it may be preferable to remove a 
few individuals rather than a small percentage of markers. 
 
The results are shown in figures 5.1 and 5.2. Figure 5.1 shows that all individuals are 
missing at least 15% of their genotype information. The Illumina 660W-Quad Beadchip 
contains a total of 95,865 non-polymorphic probes used to fill in regions under-
represented by SNPs. The percentage of missing genotypes seen in all individuals 
would correlate with the proportion of non-polymorphic probes. The total number of 
SNPs with missing genotypes was 31,371 and this represents 5.6% of all RS SNPs on the 
chip; this would appear to correlate with the 31,348 non-polymorphic probes on the 
chip assigned RS numbers. 
 
5.4.1.1.2 Sex check 
 
Males cannot be heterozygous for any markers that are on the X chromosome (that is 
not in the pseudo-autosomal region of the Y chromosome). The expected X-
chromosome male homozygosity rate is therefore 1 and that for females is < 0.2 (178). 
The X-chromosome homozygosity plot (figure 5.3) identifies a few individuals with 
atypical homozygosity ratios. The peak to the right may represent contamination or a 
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sex chromosome aberration and these individuals would need to be excluded prior to 
further analysis. 
 
5.4.1.1.3 Racial/ethnic ancestry 
 
The majority of samples cluster with HapMap III European-ancestry subjects, but there 
are clearly outliers who cluster with, for example, ethnic Indian subjects or who do not 
fall inside of any of the clusters, suggesting admixed individuals. Outliers would need to 
be excluded prior to further analysis. 
 
5.4.1.1.4 Principal component analysis 
 
GWA studies may be confounded by population stratification, whereby apparent 
differences in allele frequencies can arise as a result of divergent ancestry rather than 
the disease under study (184). Despite efforts to select cases and controls from the 
same genetically homogenous population, subtle genetic substructure may exist within 
that population and differences in this substructure between case and control cohorts 
may give rise to confounding. In the present study this was especially important 
because: 1) the PDS probands were ascertained retrospectively and formal ancestry 
history had not been taken, and 2) the PDS probands and myopic control group were 
recruited from centres in London and may therefore have had greater genetic 
heterogeneity than a similar group recruited from another part of the UK whose 
population had been more geographically stable.  
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Potential stratification was investigated by principal component analysis (PCA) (185, 
186), a statistical technique used to produce several uncorrelated variables (or 
principal components) from a dataset containing potentially correlated variables. The 
computation is such that the first principal component accounts for the maximum 
amount of variation the data in a single component; this is followed by the second 
component and so on. In the context of GWAS, the SNPs are the potentially correlated 
variables. Genotypic data from populations of known ancestry e.g. HapMap 
populations, is used to build the PCA model, which can then be applied to a GWAS 
cohort to predict principal component scores for these samples. Ten subjects in total 
did not cluster well with the rest of the group and would need to have been removed 
prior to further analysis. 
 
5.4.1.1.5 Hardy-Weinberg Equilibrium 
 
At a locus where the only alleles are ‘a’ or ‘A’, with frequencies of p and q respectively, 
the Hardy-Weinberg theorem predicts genotype frequencies of AA, Aa and aa to be p2, 
2pq and q2. SNPs demonstrating this distribution are said to be in Hardy-Weinberg 
equilibrium. Figure 5.7 shows the expected distribution of association test statistics (X-
axis) across the million SNPs compared to the observed values (Y-axis). The departure 
from the X=Y line implies a bias as the large number of SNPs represented by this 
departure could not all truly be associated with PDS. As only individuals of clear 
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European ancestry were included in this analysis this raises questions about sample 
handling or DNA quality. 
 
5.4.1.1.6 Heterozygosity 
 
Figure 5.8 illustrates the ratio of observed to expected heterozygosity. There was a 
peak at 0.75, representing individuals with a low ratio, which may be indicative of 
inbreeding (178), although this would seem unlikely given the wide catchment area of 
the clinic from which these patients were recruited. 
 
5.4.1.1.7 Relatedness 
 
Duplicate or related individuals can be identified by calculating pairwise identity-by-
state (IBS), a metric reflecting the proportion of loci at which a pair of individuals share 
the same alleles.  Only independent SNPs are used in calculating IBS and this is 
achieved by excluding extended regions of linkage disequilibrium (LD) from the data 
set (187) and editing remaining regions so that only uncorrelated SNP pairs are 
included. Identity by descent (IBD), the proportion of alleles shared in common due to 
recent shared ancestry, can be estimated from the IBS data. (175, 176). PLINK 
calculates PI-HAT, a measure of relatedness derived from IBD. The expectation for an 
outbred, contamination-free population would be to have most PI-HAT values around 
0. Peaks around 0.5 suggests two individuals are 1st degree relatives although this 
would be extremely unlikely as subjects were selected partly on the basis of being 
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unrelated to each other. Figure 5.9 shows an apparent excess of sample pairs sharing 
approximately 20% of their DNA and also a smaller portion of sample pairs sharing 
between 60 and 85% of their DNA; this degree of relatedness is uncharacteristic of 
contamination-free outbred populations. 
 
5.4.1.2  Conclusion 
 
The QC issues described above could be explained by low DNA quality and/or DNA 
contamination. DNA contamination could have arisen during pipetting of reagents: the 
laboratory work involves handling samples in 96-well plates using ‘multi-pipettes’ to 
add reagents to rows of samples at a time. Twenty-four individuals would need to be 
removed based on the QC analysis and it was felt that further analysis was precluded. 
Future efforts at conducting a GWA study into pigment dispersion syndrome would 
benefit from lessons learned from the present study: for any additional patients to be 
recruited, enquiry into ethnic ancestry should be made in order to exclude individuals 
known to be racially admixed. A 25% increase in sample size should be aimed for in 
order to allow for individuals being removed due to poor call rates and racial 
admixture. Meticulous laboratory technique should be adhered due to minimise the 
risk of sample contamination. Consideration should be given to involving other centres, 
ensuring uniform phenotyping across sites, in order to achieve the required sample size 
for the discovery and validation cohort. 
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5.4.2  Screening for GPNMB sequence variants 
 
One patient was found to have a missense change in exon 6 of GPNMB and this was 
not found to be present in 182 Caucasian control samples. This change was predicted 
to be ‘tolerated’, ‘possibly damaging’ and ‘pathological’ according to SIFT, PolyPhen-2 
and pMut respectively. The sequence is evolutionarily conserved in mice and macaques 
but not in chickens. The subject in whom the c.C325T mutation was identified did not 
have any family members who were available for phenotyping and genotyping; this 
change would need to be found in other affected relatives whilst also being absent in 
unaffected relatives in order to be considered significant. 
 
Two patients were found to have a c.-179insT in exon 1 between an M-box element 
and  a regulatory TATA-like element. The M-box element is the binding site for 
microphthalmia transcription factor, a factor that has been shown to regulate Gpnmb 
expression in murine osteoclasts (167). The M-box element is the most evolutionarily 
conserved element in the GPNMB promotor, being conserved between at least 11 
different species (167).  The variant was close to, but did not fall within, any of the 
recognised regulatory elements and this finding, together with the detection of the 
change in 1 of the control samples, makes the c.-179insT change less likely to be 
significant. 
 
Whilst mutations in GPNMB are not present in the vast majority of PDS/PG subjects, 
the detection of one non-synonymous variant indicated that the biochemical pathway 
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involving GPNMB may be relevant to the molecular basis of PDS/PG. Lu et al. (188) 
analysed gene expression in mouse strains based on the presence or absence of the 
R150X Gpnmb mutation and reported that the mutation radically alters the set of 
genes with which Gpnmb expression is correlated and have described different co-
expression networks of genes associated with the mutant and wild-type transcripts. 
Human homologues of genes in both of these networks would be candidate genes for 
PDS/PG in man. 
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6 SUMMARY 
 
AS-OCT provides a means to image iris curvature in a relatively physiological way and 
offers certain advantages over UBM. The results of the agreement study described in 
chapter 2 validated its use in the measurement of iris concavity. The main 
disadvantage of AS-OCT, however, is the inability to clearly identify areas of irido-
lenticular contact, an important parameter to consider when investigating the 
pathophysiology of pigment dispersion and the effect of LPI. The results of the case-
control study indicated that non-accommodative iris concavity is the parameter that 
best distinguishes cases from controls and this corroborates published data indicating 
that the increase in iris concavity seen with accommodation is relatively transient and 
that the iris reverts to a more convex configuration despite accommodative effort 
being maintained.  
 
LPI in PDS patients is a controversial intervention and robust evidence supporting its 
use is currently lacking. Ideally a longitudinal, prospective randomized control trial is 
needed to compare the effect of LPI on the risk of developing subsequent PG. Iris 
curvature assessments would form an important part of such a study as it would be 
useful to record any change in iris curvature pre- and post-LPI; whilst changes have 
been demonstrated in a cross-sectional study using UBM (81), longitudinal studies have 
not attempted to correlate imaging changes with the risk of developing raised IOP (35) 
or PG (55). 
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Although the results of the present study suggest good agreement with respect to 
measurements on individual AS-OCT images, whether curvature measurements taken 
on the same patient several hours or several days apart are repeatable has not been 
established. Future work should therefore assess the repeatability of these 
measurements over different time points. Fundus autofluorescence imaging represents 
an important tool to further investigate posterior segment changes in PDS/PG. 
 
Age was significantly associated with iris curvature in both PDS/PG subjects and 
controls; this association was detected for non-accommodative as well as 
accommodative iris curvature and was stronger for the latter. The mechanism for the 
increased concavity on accommodation is not entirely clear; it is unlikely to be purely 
due to anterior lens movement as it is recognised that increased concavity is short-
lived despite continued accommodation. The slope of the curve for age against 
accommodative iris curvature levels off after 50 years of age and this may well 
correspond to the reduction in accommodative amplitude associated with presbyopia. 
 
Whilst iris concavity is a frequent finding in PDS, it can also occur in normal subjects 
and appears to be more common in younger, more myopic individuals. Chapter 3 
described a study conducted primarily to investigate the prevalence of iris concavity in 
a cohort of 10-12 year old boys. Relationships between iris curvature and corneal 
biomechanical properties and anterior segment biometry were explored and the 
cohort was revisited 2 years later using an identical data collection protocol. In 
addition, reported birth weight and measures of height, weight, waist circumference, 
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digit ratio and percentage body fat were taken in order to explore relationships with 
myopia. Iris concavity was a common finding in this cohort at baseline and increased in 
prevalence at the 2-year follow up visit. At both time points iris curvature was related 
to lens vault, anterior chamber depth and scleral spur angle.  Significant association 
was detected between corneal hysteresis, a parameter thought to represent corneal 
biomechanical properties, and spur-to-spur distance as measured on horizontal AS-OCT 
imaging. Screening children of PDS/PG patients for iris concavity on AS-OCT is unlikely 
to be a useful predictor for development of PDS/PG in adulthood.   
 
Chapter 4 described the results of linkage analysis conducted on a multigenerational 
family segregating for autosomal dominant PDS/PG. Linkage to the 2 known PDS/PG 
loci was excluded. Three chromosomal regions of interest were identified and coding 
regions of candidate genes in in the region identified on chromosome 1 were 
sequenced in one affected and one unaffected member of the pedigree. No 
pathological sequence variants were identified. Assumptions were made regarding the 
presumptive affected/unaffected status for deceased individuals that previously 
provided blood samples for genetic studies into PDS/PG as well as the likely aetiology 
of GON in older members of the family who did not at the time of examination meet 
diagnostic criteria for pigment dispersion. In addition, the genetic model underlying the 
linkage analysis made assumptions e.g. that the disease causing allele is fully 
penetrant, which cannot, prior to identifying a causative mutation, be verified. Whilst 
there is the possibility that the regions identified may represent false positives, the 
development of next generation sequencing, a technology that permits rapid, high 
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throughput sequencing provides an opportunity for the relatively wide regions of 
interest to be investigated for putative disease causing variants. In the course of 
searching for additional families that were suitable for linkage analysis, several smaller 
families have been recruited with between 1 and 3 affected members and these 
represents a valuable resource which could be screened for the purpose of attempting 
to validate any pathological sequence variants that might be identified in the future. 
 
Whilst linkage analysis has been shown to be a powerful technique to identify rare 
variants with a large effect size, population based association studies are more 
appropriate for identifying more common alleles with a smaller effect size. High-
density oligonucleotide microarrays have enabled the investigation of genome-wide 
association in more detail with smaller sample sizes than was previously possible. The 
first part of chapter 5 described efforts to conduct a pilot GWAS involving pigment 
dispersion samples from PDS/PG patients to identify associated genomic regions. DNA 
was extracted from these samples and sent to a commercial genotyping service. 
Genetic epidemiologists conducted the following quality control checks on the raw SNP 
calls according to a published protocol: missing SNP calls, gender checks, racial/ethnic 
ancestry checks, departure from Hardy-Weinberg equilibrium, heterozygosity and 
relatedness. Unfortunately the analysis identified significant problems with the 
genotypic data which implicated low quality DNA or sample contamination and this 
precluded taking the data forward to the association stage. Residual DNA from a 
number of subjects is still available and, providing the above issues could be addressed 
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and additional patients recruited to achieve the required sample size, it would still be 
possible to proceed with a genome-wide association study. 
 
Murine Gpnmb codes for a transmembrane glycoprotein protein and a mutation in this 
gene giving rise to a premature stop codon causes the iris pigment dispersion 
phenotype in DBA/2J mice. The human homologue, located at chromosome 7p15, was 
considered an excellent candidate for pigment dispersion in man. The second part of 
chapter 5 reported on the sequencing of the promotor and coding regions of this gene 
in a panel of unrelated PDS/PG subjects. One patient was found to have a missense 
change in exon 6, not found to be present in a panel of 182 Caucasian control samples. 
Whilst this change gives rise to a change in the amino acid sequence, analyses on the 
significance of this change gave conflicting results. Two patients were found to have a 
c.-179insT in exon 1 proximal to the TATA-like element regulatory region; the 
identification of this change in 1 of the control samples suggests that it may not be 
significant. No other variants in GPNMB were detected in the remaining 93 samples. 
 
There are a number of directions for future work building on the work described in the 
thesis. The key next studies would be: 
 
1. Exploring the repeatability of iris curvature measurements with AS-OCT over 
multiple time points. This would be a key study in validating AS-OCT as a tool for 
quantifying iris curvature. 
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2. A prospective longitudinal RCT investigating the effect of LPI on the risk of 
developing raised IOP, using the fellow eye as a control eye. The results of the 
Gandolfi study (35) would be used in the power calculation to determine an 
appropriate sample size. PDS subjects without OHT or GON would need to be 
actively recruited from the community in an effort to minimise ascertainment 
bias that would arise from recruiting from a hospital-based glaucoma clinic. 
Following the untreated eye would provide valuable data on the natural history 
of PDS. 
 
3. Analysis of the PDS pedigree described in Chapter 4 using exome sequencing, 
a technology that would provide sequencing data for coding regions across the 
whole genome for all family members. The results of the linkage analysis 
would be used to focus on those regions already found to have promising LOD 
scores in order to narrow down search for variants segregating with affected 
family members. 
 
4. Further recruitment of PDS subjects for the GWA study. Rigorous testing of 
extracted DNA would need to be performed with meticulous attention to 
laboratory technique in order to minimise the risk of DNA contamination.  
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7 APPENDIX 
 
7.1  Protocol for DNA preparation prior to genotyping on Affymetrix 50K 
Genechip 
 
7.2 Protocol for ethanol precipitation for extracted DNA samples not 
meeting QC criteria on spectrophotometry 
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Appendix 1 Protocol for DNA preparation prior to genotyping on Affymetrix 50K 
Genechip 
 
DNA was prepared according to the following protocol prior to sending samples to the 
Wolfson Institute for Biomedical Research (WIBR) for hybridisation, washing/staining 
and scanning. The volumes of reagent indicated are per sample of DNA unless 
otherwise stated. 
 
Digestion 
The following digestion master mix was prepared in a DNA/amplicon free hood.  
Nuclease-free H20 12.3 µl 
NE Buffer 2(10X) 2 µl 
BSA  (10X (1mg/ml) 0.2µl 
XbaI (20U/ul)  0.5 µl 
Total   15 µl 
 
15 µl of master mix was added to 5 µl of the previously diluted DNA. 
The samples were run in a thermal cycler at 37˚C for 2 hours then 70˚C for 20 mins. 
 
Ligation 
The following master mix was prepared on ice: 
Adaptor Xba (5M) 1.25 l 
T4 DNA ligase buffer (10x) 2.5 l 
T4 LIGASE (400U/l) 0.625 l 
H2O 0.625 l 
Total 5 l 
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5 l of the ligase mix was added to 20 l of digested DNA.  
The samples were run in a thermal cycler at 16˚C for 2 hours then 70˚C for 20 mins. 
75 l nuclease-free H20 was added to the 25 l ligated solution. 
 
Polymerase chain reaction (PCR) 
The following master mix was prepared on ice: 
H2O 132 l 
Pfx buffer 30 l 
PCR enhancer 30 l 
MgSO4 (50mM) 6 l 
dNTP (2.5mM) 36 l 
PCR Primer (10M) 30 l 
Pfx Polymerase  6 l 
Total 270 μl 
 
The total volume per sample of 270 μl was aliquoted into 3 tubes of 90 μl each. 10 μl of 
diluted ligated DNA was mixed with 90 μl of PCR master mix. Three batches per DNA 
sample were prepared. The samples were run in a thermal cycler as follows: 
Initial denaturation 94˚C for 3 min 1 cycle 
Denaturation 
Annealing 
Extension 
94˚C for 30 s 
60˚C for 45 s 
68˚C for 1 min 
 
30 cycles 
Final extension 68˚C for 7 min 1 cycle 
 
4 μl of each PCR product was mixed with 1 μl loading dye on 2% tris-acetate-EDTA gel 
at 120V for 1 hour. 
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Purification, quantification and normalization 
The three PCR reactions for each sample were consolidated into one well of a MinElute 
plate. A vacuum of 800 mmHg was applied until the wells were completely dry. PCR 
products were washed by adding 50 μl nuclease-free water and maintaining the 
vacuum until the wells were completely empty. This step was repeated 2 additional 
times for a total of 3 water washes. The vacuum source was then switched off and the 
MinElute plate was removed from the vacuum manifold.  40 μl EB buffer was added to 
each well. A plastic plate sealer was applied and the plate was shaken for 5 minutes at 
moderate speed. The re-suspended samples were then pipetted into a clean plate. 2 l 
of sample was quantified on a Nanodrop spectrophotometer. Samples were 
normalized to 40 g/45 l using EB. 
 
Fragmentation 
45 L purified PCR product was mixed with 5 l 10x Fragmentation Buffer (FB), 
vortexed for 2 seconds and placed back on ice. This mixture constitutes the 
Fragmentation PCR Mix (FPM). 
Fragmentation reagent was diluted as follows:  
REAGENTS 3U/L 
FR (DNase I) 2 L 
FB X10 15 L 
H2O 133 L 
 
This was vortexed for 2 seconds and placed back on ice. 5 l diluted FR was mixed with 
50 l FPM, vortexed for 2 seconds and placed back on ice. The samples were run on a 
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thermal cycler as at 37˚C for 30mins and then 95˚C for 15 mins. 4 L of product was 
run on a 4% tris-acetete-EDTA agarose gel at 120V. 
 
Labelling 
Labelling master mix (LMM) was prepared on ice as follows: 
5x TdT Buffer 14 l 
GeneChip DNA Labeling Reagent (7.5mM) 2 l 
TdT (30U/L) 3.5 l 
TOTAL 19.5 l 
 
The mixture was vortexed for 2 seconds and placed back on ice. 19.5 L LMM was 
added to 50.5 l of fragmented sample on ice, vortexed for 2 seconds and placed back 
on ice. The samples were then run on a thermal cycler at 37˚C for 2hours and then 
95˚C for 15 mins. Samples were then stored at -20˚C. 
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Appendix 2 Protocol for ethanol precipitation for extracted DNA samples not 
meeting QC criteria on spectrophotometry 
 
50 µl of DNA was mixed with 5 µl of 3M sodium acetate and 125 µl 100 % ethanol.  
This was briefly vortexed and spun for 20 minutes in a centrifuge at 12000 rpm at 4°C. 
The supernatant was carefully aspirated and discarded taking care not to aspirate the 
DNA pellet at the base of the tube. 
 
1 mL of cold 70% ethanol was added. This was spun for 10 minutes at 12000 rpm at 4°C 
and the supernatant was carefully aspirated and discarded as above. The DNA pellet 
was left to air dry for 10 minutes at room temperature and dissolved in 40 µl Elution 
Buffer (EB) (10 mM Tris-HCl pH 7.5). The optical density of the eluted DNA was 
measured using a NanoDrop spectrophotometer. The ratio of absorbance at 260 nm 
and 280 nm of approximately 1.8 was considered acceptable and a ratio of absorbance 
at 260 nm and 230 nm between 1.8 and 2.2 was considered acceptable. DNA was 
diluted to a concentration of 50 ng/µl. 
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